BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature. 1996;379:645-648. [PMID: 8628398 DOI: 10.1038/379645a0] [Cited by in Crossref: 669] [Cited by in F6Publishing: 661] [Article Influence: 25.7] [Reference Citation Analysis]
Number Citing Articles
1 Kakar R, Kautz B, Eklund EA. JAK2 is necessary and sufficient for interferon-γ-induced transcription of the gene encoding gp91 PHOX. Journal of Leukocyte Biology 2005;77:120-7. [DOI: 10.1189/jlb.0704429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
2 Gu L, Zhuang H, Safina B, Xiao XY, Bradford WW, Rich BE. Combinatorial approach to identification of tyrphostin inhibitors of cytokine signaling. Bioorg Med Chem 2005;13:4269-78. [PMID: 15869881 DOI: 10.1016/j.bmc.2005.04.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Moulin S, Bouzinba-segard H, Kelly PA, Finidori J. Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure. Cellular Signalling 2003;15:47-55. [DOI: 10.1016/s0898-6568(02)00054-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Dent G, Munoz NM, Zhu X, Rühlmann E, Magnussen H, Leff AR, Rabe KF. Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. Immunology 2000;100:231-7. [PMID: 10886400 DOI: 10.1046/j.1365-2567.2000.00037.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
5 Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol 2002;22:3316-26. [PMID: 11971965 DOI: 10.1128/MCB.22.10.3316-3326.2002] [Cited by in Crossref: 183] [Cited by in F6Publishing: 88] [Article Influence: 9.2] [Reference Citation Analysis]
6 Murakami Y, Nakano S, Niho Y, Hamasaki N, Izuhara K. Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line. J Cell Physiol 1998;175:220-8. [DOI: 10.1002/(sici)1097-4652(199805)175:2<220::aid-jcp12>3.0.co;2-c] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Avtanski DB, Nagalingam A, Bonner MY, Arbiser JL, Saxena NK, Sharma D. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Mol Oncol 2014;8:565-80. [PMID: 24508063 DOI: 10.1016/j.molonc.2014.01.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 8.3] [Reference Citation Analysis]
8 Trivedi S, Starz-Gaiano M. Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis. Int J Mol Sci 2018;19:E4056. [PMID: 30558204 DOI: 10.3390/ijms19124056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
9 Valle-mendiola A, Weiss-steider B, Rocha-zavaleta L, Soto-cruz I. IL-2 Enhances Cervical Cancer Cells Proliferation and JAK3/STAT5 Phosphorylation at Low Doses, While at High Doses IL-2 Has Opposite Effects. Cancer Investigation 2014;32:115-25. [DOI: 10.3109/07357907.2014.883526] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
10 Sur R, Hall J, Cavender D, Malaviya R. Role of Janus kinase-2 in IgE receptor-mediated leukotriene C4 production by mast cells. Biochemical and Biophysical Research Communications 2009;390:786-90. [DOI: 10.1016/j.bbrc.2009.10.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Guo C, Su J, Li Z, Xiao R, Wen J, Li Y, Zhang M, Zhang X, Yu D, Huang W, Chen WD, Wang YD. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway. Oncotarget 2015;6:34402-13. [PMID: 26417930 DOI: 10.18632/oncotarget.5353] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
12 Rogers SW, Gahring LC. Upregulation of Nicotinic Acetylcholine Receptor alph4+beta2 through a Ligand-Independent PI3Kbeta Mechanism That Is Enhanced by TNFalpha and the Jak2/p38Mapk Pathways. PLoS One 2015;10:e0143319. [PMID: 26619345 DOI: 10.1371/journal.pone.0143319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Mascareno E, Beckles DL, Siddiqui M. Janus kinase-2 signaling mediates apoptosis in rat cardiomyocytes. Vascular Pharmacology 2005;43:327-35. [DOI: 10.1016/j.vph.2005.08.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
14 Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol. 2004;6:547-554. [PMID: 15156153 DOI: 10.1038/ncb1138] [Cited by in Crossref: 293] [Cited by in F6Publishing: 283] [Article Influence: 16.3] [Reference Citation Analysis]
15 Bose S, Banerjee S, Mondal A, Chakraborty U, Pumarol J, Croley CR, Bishayee A. Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy. Cells 2020;9:E1451. [PMID: 32545187 DOI: 10.3390/cells9061451] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
16 Zhang K, Guo W, Yang Y, Wu J. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPβ transcription. J Cell Biochem 2011;112:488-97. [PMID: 21268070 DOI: 10.1002/jcb.22936] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
17 Pachuau J, Martin-Caraballo M. Extrinsic regulation of T-type Ca(2+) channel expression in chick nodose ganglion neurons. Dev Neurobiol 2007;67:1915-31. [PMID: 17874459 DOI: 10.1002/dneu.20560] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ito T, May WS. Drug development train gathering steam. Nat Med 1996;2:403-4. [DOI: 10.1038/nm0496-403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
19 Venema RC, Venema VJ, Eaton DC, Marrero MB. Angiotensin II-induced Tyrosine Phosphorylation of Signal Transducers and Activators of Transcription 1 Is Regulated by Janus-activated Kinase 2 and Fyn Kinases and Mitogen-activated Protein Kinase Phosphatase 1. Journal of Biological Chemistry 1998;273:30795-800. [DOI: 10.1074/jbc.273.46.30795] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 2.8] [Reference Citation Analysis]
20 Smal C, Cardoen S, Bertrand L, Delacauw A, Ferrant A, Berghe GVD, Neste EVD, Bontemps F. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells. Biochemical Pharmacology 2004;68:95-103. [DOI: 10.1016/j.bcp.2004.02.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
21 Zhao Z, Mao Z, Yin J, Shu Y, Qiu W, Lu Z, Hu X. Immune characteristics study of AG490, a signal pathway inhibitor, in EAE model mice. Saudi J Biol Sci 2017;24:256-62. [PMID: 28149160 DOI: 10.1016/j.sjbs.2016.08.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Constantin G, Brocke S, Izikson A, Laudanna C, Butcher EC. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis. Eur J Immunol 1998;28:3523-9. [DOI: 10.1002/(sici)1521-4141(199811)28:11<3523::aid-immu3523>3.0.co;2-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
23 Iversen PO, Lewis ID, Turczynowicz S, Hasle H, Niemeyer C, Schmiegelow K, Bastiras S, Biondi A, Hughes TP, Lopez AF. Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Prevents Dissemination and Induces Remission of Juvenile Myelomonocytic Leukemia in Engrafted Immunodeficient Mice. Blood 1997;90:4910-7. [DOI: 10.1182/blood.v90.12.4910] [Cited by in Crossref: 40] [Article Influence: 1.6] [Reference Citation Analysis]
24 Levitzki A. Protein Kinase Inhibitors. Handbook of Cell Signaling. Elsevier; 2003. pp. 451-61. [DOI: 10.1016/b978-012124546-7/50438-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 He HJ, Zhu TN, Xie Y, Fan J, Kole S, Saxena S, Bernier M. Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytes. J Biol Chem 2006;281:31369-79. [PMID: 16926159 DOI: 10.1074/jbc.M603762200] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
26 Levitzki A. Targeting signal transduction for disease therapy. Med Oncol 1997;14:83-9. [DOI: 10.1007/bf02990952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Häusler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch U. Interferon-γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages: IFNg modulation of microglial release activity. European Journal of Neuroscience 2002;16:2113-22. [DOI: 10.1046/j.1460-9568.2002.02287.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 4.4] [Reference Citation Analysis]
28 Richardson JH, Waldmann TA, Sodroski JG, Marasco WA. Inducible knockout of the interleukin-2 receptor alpha chain: expression of the high-affinity IL-2 receptor is not required for the in vitro growth of HTLV-I-transformed cell lines. Virology 1997;237:209-16. [PMID: 9356333 DOI: 10.1006/viro.1997.8779] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
29 Stahl P, Waldmann H. Asymmetrische Synthese der Nakijichinone – selektive Inhibitoren des Her-2/Neu-Protoonkogens. Angewandte Chemie 1999;111:3935-8. [DOI: 10.1002/(sici)1521-3757(19991216)111:24<3935::aid-ange3935>3.0.co;2-x] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
30 Waldmann H, Hinterding K, Herrlich P, Rahmsdorf HJ, Knebel A. Selektive Inhibierung von Rezeptor-Tyrosinkinasen mit Aeroplysinin-Analoga. Angew Chem 1997;109:1553-5. [DOI: 10.1002/ange.19971091328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
31 Zhang F, Zhang Q, Tengholm A, Sjöholm Å. Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca 2+ and insulin secretion. American Journal of Physiology-Cell Physiology 2006;291:C466-75. [DOI: 10.1152/ajpcell.00418.2005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
32 Kox M, van Velzen JF, Pompe JC, Hoedemaekers CW, van der Hoeven JG, Pickkers P. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem Pharmacol 2009;78:863-72. [PMID: 19576181 DOI: 10.1016/j.bcp.2009.06.096] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
33 Hao X, Cao D, Hu Y, Li X, Liu X, Xiao J, Liao D, Xiang J, Tang C. IFN-γ down-regulates ABCA1 expression by inhibiting LXRα in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 2009;203:417-28. [DOI: 10.1016/j.atherosclerosis.2008.07.029] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
34 Watanabe D, Ezoe S, Fujimoto M, Kimura A, Saito Y, Nagai H, Tachibana I, Matsumura I, Tanaka T, Kanegane H, Miyawaki T, Emi M, Kanakura Y, Kawase I, Naka T, Kishimoto T. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines: SOCS-1 Gene Silencing in AML. British Journal of Haematology 2004;126:726-35. [DOI: 10.1111/j.1365-2141.2004.05107.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
35 Dorritie KA, Redner RL, Johnson DE. STAT transcription factors in normal and cancer stem cells. Adv Biol Regul 2014;56:30-44. [PMID: 24931719 DOI: 10.1016/j.jbior.2014.05.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
36 Jeng MH, Yue W, Eischeid A, Wang JP, Santen RJ. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells. Breast Cancer Res Treat. 2000;62:167-175. [PMID: 11072781 DOI: 10.1023/a:1006406030612] [Cited by in Crossref: 67] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
37 Hayakawa F, Towatari M, Iida H, Wakao H, Kiyoi H, Naoe T, Saito H. Differential constitutive activation between STAT‐related proteins and MAP kinase in primary acute myelogenous leukaemia. British Journal of Haematology 2001;101:521-8. [DOI: 10.1046/j.1365-2141.1998.00720.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
38 Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol. 2003;171:3863-3871. [PMID: 14500688 DOI: 10.4049/jimmunol.171.7.3863] [Cited by in Crossref: 345] [Cited by in F6Publishing: 309] [Article Influence: 19.2] [Reference Citation Analysis]
39 Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BK, Sethi G, Bishayee A. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta. 2014;1845:136-154. [PMID: 24388873 DOI: 10.1016/j.bbcan.2013.12.005] [Cited by in Crossref: 166] [Cited by in F6Publishing: 296] [Article Influence: 20.8] [Reference Citation Analysis]
40 Hayashi M, Rho MC, Enomoto A, Fukami A, Kim YP, Kikuchi Y, Sunazuka T, Hirose T, Komiyama K, Omura S. Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130. Proc Natl Acad Sci U S A 2002;99:14728-33. [PMID: 12417753 DOI: 10.1073/pnas.232562799] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
41 Levitzki A. Protein Kinase Inhibitors as a Therapeutic Modality. Acc Chem Res 2003;36:462-9. [DOI: 10.1021/ar0201207] [Cited by in Crossref: 128] [Cited by in F6Publishing: 104] [Article Influence: 6.7] [Reference Citation Analysis]
42 Gilabert M, Calvo E, Airoldi A, Hamidi T, Moutardier V, Turrini O, Iovanna J. Pancreatic cancer-induced cachexia is Jak2-dependent in mice. J Cell Physiol. 2014;229:1437-1443. [PMID: 24648112 DOI: 10.1002/jcp.24580] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
43 Lakshmikuttyamma A, Pastural E, Takahashi N, Sawada K, Sheridan DP, Decoteau JF, Geyer CR. Bcr-Abl induces autocrine IGF-1 signaling. Oncogene 2008;27:3831-44. [DOI: 10.1038/onc.2008.8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
44 Vieira AS, Araldi D, Dias EV, do Prado FC, Tambeli CH, Parada CA. Janus kinase 2 activation participates in prostaglandin E2-induced hyperalgesia. Life Sci 2016;166:8-12. [PMID: 27717845 DOI: 10.1016/j.lfs.2016.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998;188:421-9. [PMID: 9687520 DOI: 10.1084/jem.188.3.421] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 4.3] [Reference Citation Analysis]
46 Wang H, Byfield G, Jiang Y, Smith GW, McCloskey M, Hartnett ME. VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am J Pathol 2012;180:1243-53. [PMID: 22230249 DOI: 10.1016/j.ajpath.2011.11.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
47 Walrafen P, Verdier F, Kadri Z, Chrétien S, Lacombe C, Mayeux P. Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 2005;105:600-8. [DOI: 10.1182/blood-2004-03-1216] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 7.4] [Reference Citation Analysis]
48 Li H, Xu W, Liu X, Wang T, Wang S, Liu J, Jiang H. JAK2 deficiency improves erectile function in diabetic mice through attenuation of oxidative stress, apoptosis, and fibrosis. Andrology 2021. [PMID: 34085398 DOI: 10.1111/andr.13061] [Reference Citation Analysis]
49 Duy C, Hurtz C, Shojaee S, Cerchietti L, Geng H, Swaminathan S, Klemm L, Kweon SM, Nahar R, Braig M, Park E, Kim YM, Hofmann WK, Herzog S, Jumaa H, Koeffler HP, Yu JJ, Heisterkamp N, Graeber TG, Wu H, Ye BH, Melnick A, Müschen M. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature 2011;473:384-8. [PMID: 21593872 DOI: 10.1038/nature09883] [Cited by in Crossref: 141] [Cited by in F6Publishing: 134] [Article Influence: 12.8] [Reference Citation Analysis]
50 Siavash H, Nikitakis NG, Sauk JJ. Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. Br J Cancer 2004;91:1074-80. [PMID: 15316561 DOI: 10.1038/sj.bjc.6602055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
51 Mukhopadhyay A, Basu SK. Intracellular Delivery of Drugs to Macrophages. In: Ghose TK, Ghosh P, Basu SK, Bhardwaj D, Chauhan VS, Dhar N, Johri BN, Khurana JP, Mukhopadhyay A, Padmanaban G, Sharma A, Sharma M, Swarup R, Tyagi AK, Virdi JS, editors. Biotechnology in India I. Berlin: Springer Berlin Heidelberg; 2003. pp. 183-209. [DOI: 10.1007/3-540-36488-9_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Samaan A, Mahana W. Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines. Immunol Lett. 2007;109:113-119. [PMID: 17368812 DOI: 10.1016/j.imlet.2007.01.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
53 Shideman CR, Hu S, Peterson PK, Thayer SA. CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism. J Neurosci Res 2006;83:1471-84. [PMID: 16547971 DOI: 10.1002/jnr.20839] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
54 Senft C, Priester M, Polacin M, Schröder K, Seifert V, Kögel D, Weissenberger J. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 2011;101:393-403. [PMID: 20589525 DOI: 10.1007/s11060-010-0273-y] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
55 Dutta P, Sabri N, Li J, Li WX. Role of STAT3 in lung cancer. JAKSTAT 2014;3:e999503. [PMID: 26413424 DOI: 10.1080/21623996.2014.999503] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
56 Umezawa K. Induction of cellular differentiation and apoptosis by signal transduction inhibitors. Advances in Enzyme Regulation 1997;37:393-401. [DOI: 10.1016/s0065-2571(96)00022-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
57 Mellott T, Lopez-Coviella I, Blusztajn JK, Berse B. Mitogen-activated protein kinase kinase negatively modulates ciliary neurotrophic factor-activated choline acetyltransferase gene expression. Eur J Biochem 2002;269:850-8. [PMID: 11846786 DOI: 10.1046/j.0014-2956.2001.02717.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
58 Peña G, Cai B, Liu J, van der Zanden EP, Deitch EA, de Jonge WJ, Ulloa L. Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis. Eur J Immunol 2010;40:2580-9. [PMID: 20706987 DOI: 10.1002/eji.201040540] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
59 Huang C, Yang G, Jiang T, Huang K, Cao J, Qiu Z. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro. J Exp Clin Cancer Res. 2010;29:51. [PMID: 20482858 DOI: 10.1186/1756-9966-29-51] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
60 Ben-bassat H, Hartzstark Z, Levitzki R, Klein BY, Shlomai Z, Gazit A, Levitzki A. Tyrosine Kinase Inhibitors Suppress the Growth of Non-Hodgkin B Lymphomas. J Pharmacol Exp Ther 2002;303:163-71. [DOI: 10.1124/jpet.102.036723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Ward AC, Touw I, Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 2000;95:19-29. [DOI: 10.1182/blood.v95.1.19.001k34_19_29] [Cited by in Crossref: 28] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
62 Lee Jr J, Mccubrey J. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 2002;16:486-507. [DOI: 10.1038/sj.leu.2402460] [Cited by in Crossref: 168] [Cited by in F6Publishing: 160] [Article Influence: 8.4] [Reference Citation Analysis]
63 Kirito K, Nakajima K, Watanabe T, Uchida M, Tanaka M, Ozawa K, Komatsu N. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood 2002;99:102-10. [DOI: 10.1182/blood.v99.1.102] [Cited by in Crossref: 60] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
64 Nakashima O, Terada Y, Hanada S, Yamamoto K, Kuwahara M, Sasaki S, Marumo F. Activated STAT1 suppresses proliferation of cultured rat mesangial cells. Kidney International 2000;57:2249-57. [DOI: 10.1046/j.1523-1755.2000.00085.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
65 Mendes A, Caramona M, Carvalho A, Lopes M. Role of Mitogen-Activated Protein Kinases and Tyrosine Kinases on IL-1-Induced NF-κB Activation and iNOS Expression in Bovine Articular Chondrocytes. Nitric Oxide 2002;6:35-44. [DOI: 10.1006/niox.2001.0378] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
66 Spaner DE. Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells. Journal of Leukocyte Biology 2004;76:338-51. [DOI: 10.1189/jlb.0104016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
67 Shaw S, Bencherif M, Marrero MB. Janus Kinase 2, an Early Target of α7 Nicotinic Acetylcholine Receptor-mediated Neuroprotection against Aβ-(1–42) Amyloid. Journal of Biological Chemistry 2002;277:44920-4. [DOI: 10.1074/jbc.m204610200] [Cited by in Crossref: 135] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
68 Thabard W, Collette M, Mellerin M, Puthier D, Barillé S, Bataille R, Amiot M. IL-6 UPREGULATES ITS OWN RECEPTOR ON SOME HUMAN MYELOMA CELL LINES. Cytokine 2001;14:352-6. [DOI: 10.1006/cyto.2001.0911] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
69 Adachi K, Tanaka T, Saito H, Oka T. Hormonal Induction of Mouse Selenocysteine Transfer Ribonucleic Acid (tRNA) Gene Transcription-Activating Factor and Its Functional Importance in the Selenocysteine tRNA Gene Transcription in Mouse Mammary Gland. Endocrinology 1999;140:618-23. [DOI: 10.1210/endo.140.2.6501] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
70 Yang SH, Khadka DB, Cho SH, Ju H, Lee KY, Han HJ, Lee K, Cho W. Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors. Bioorganic & Medicinal Chemistry 2011;19:968-77. [DOI: 10.1016/j.bmc.2010.11.057] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
71 Glavaski-joksimovic A, Rowe EW, Jeftinija K, Scanes CG, Anderson LL, Jeftinija S. Effects of Leptin on Intracellular Calcium Concentrations in Isolated Porcine Somatotropes. Neuroendocrinology 2004;80:73-82. [DOI: 10.1159/000081843] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
72 Ma R, Hu J, Huang C, Wang M, Xiang J, Li G. JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35. Br J Pharmacol. 2014;171:3234-3245. [PMID: 24597613 DOI: 10.1111/bph.12672] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
73 Byfield G, Budd S, Hartnett ME. The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. Invest Ophthalmol Vis Sci 2009;50:3360-5. [PMID: 19264880 DOI: 10.1167/iovs.08-3256] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
74 Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J Biol Chem. 2000;275:24935-24944. [PMID: 10823829 DOI: 10.1074/jbc.m002383200] [Cited by in Crossref: 120] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
75 Baeyens L, Bonné S, German MS, Ravassard P, Heimberg H, Bouwens L. Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway. Cell Death Differ 2006;13:1892-9. [PMID: 16514419 DOI: 10.1038/sj.cdd.4401883] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
76 Yamauchi T, Yamauchi N, Ueki K, Sugiyama T, Waki H, Miki H, Tobe K, Matsuda S, Tsushima T, Yamamoto T, Fujita T, Taketani Y, Fukayama M, Kimura S, Yazaki Y, Nagai R, Kadowaki T. Constitutive Tyrosine Phosphorylation of ErbB-2 via Jak2 by Autocrine Secretion of Prolactin in Human Breast Cancer. Journal of Biological Chemistry 2000;275:33937-44. [DOI: 10.1074/jbc.m000743200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
77 Shi S, Xiao X, Czarnik AW. A combinatorial synthesis of tyrphostins via the “directed sorting” method. Biotechnol Bioeng 1998;61:7-12. [DOI: 10.1002/(sici)1097-0290(199824)61:1<7::aid-bit4>3.0.co;2-n] [Cited by in Crossref: 18] [Article Influence: 0.8] [Reference Citation Analysis]
78 Vieira SA, Deininger MW, Sorour A, Sinclair P, Foroni L, Goldman JM, Melo JV. Transcription factor BACH2 is transcriptionally regulated by theBCR/ABL oncogene. Genes Chromosom Cancer 2001;32:353-63. [DOI: 10.1002/gcc.1200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
79 Jasuja H, Chadha N, Kaur M, Silakari O. Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore- and docking-based virtual screening approach. Mol Divers 2014;18:253-67. [PMID: 24415188 DOI: 10.1007/s11030-013-9497-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
80 Natarajan C, Sriram S, Muthian G, Bright JJ. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia. Glia 2004;45:188-96. [PMID: 14730712 DOI: 10.1002/glia.10316] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
81 Weber-Nordt RM, Mertelsmann R, Finke J. The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation. Leuk Lymphoma 1998;28:459-67. [PMID: 9613975 DOI: 10.3109/10428199809058353] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
82 McKenna SL, Cotter TG. Functional aspects of apoptosis in hematopoiesis and consequences of failure. Adv Cancer Res 1997;71:121-64. [PMID: 9111865 DOI: 10.1016/s0065-230x(08)60098-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
83 Beswick EJ, Johnson JR, Saada JI, Humen M, House J, Dann S, Qiu S, Brasier AR, Powell DW, Reyes VE, Pinchuk IV. TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells. J Immunol 2014;193:2218-29. [PMID: 25070848 DOI: 10.4049/jimmunol.1203441] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
84 Anaissi A, Kennedy PJ, Goyal M, Catchpoole DR. A balanced iterative random forest for gene selection from microarray data. BMC Bioinformatics 2013;14:261. [PMID: 23981907 DOI: 10.1186/1471-2105-14-261] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
85 Chen AY, Guan W, Lou S, Liu Z, Kleiboeker S, Qiu J. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol 2010;84:12385-96. [PMID: 20861249 DOI: 10.1128/JVI.01229-10] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
86 Williams L, Lali F, Clarke C, Brennan F, Foxwell B. INTERLEUKIN 10 MODULATION OF TUMOUR NECROSIS FACTOR RECEPTORS REQUIRES TYROSINE KINASES BUT NOT THE PI 3-KINASE/p70 S6 KINASE PATHWAY. Cytokine 2000;12:934-43. [DOI: 10.1006/cyto.1999.0673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
87 Araújo JR, Correia-Branco A, Moreira L, Ramalho C, Martel F, Keating E. Folic acid uptake by the human syncytiotrophoblast is affected by gestational diabetes, hyperleptinemia, and TNF-α. Pediatr Res 2013;73:388-94. [PMID: 23338599 DOI: 10.1038/pr.2013.14] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
88 Channon JY, Miselis KA, Minns LA, Dutta C, Kasper LH. Toxoplasma gondii induces granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor secretion by human fibroblasts: implications for neutrophil apoptosis. Infect Immun 2002;70:6048-57. [PMID: 12379681 DOI: 10.1128/IAI.70.11.6048-6057.2002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
89 Singh BN, Singh HB, Singh A, Naqvi AH, Singh BR. Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade. Cancer Metastasis Rev 2014;33:41-85. [PMID: 24390421 DOI: 10.1007/s10555-013-9457-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
90 Cochet O, Frelin C, Peyron JF, Imbert V. Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival. Cell Signal 2006;18:449-55. [PMID: 15967637 DOI: 10.1016/j.cellsig.2005.05.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
91 Tsuchiya Y, Takahashi N, Yoshizaki T, Tanno S, Ohhira M, Motomura W, Tanno S, Takakusaki K, Kohgo Y, Okumura T. A Jak2 inhibitor, AG490, reverses lipin-1 suppression by TNF-alpha in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2009;382:348-52. [PMID: 19281795 DOI: 10.1016/j.bbrc.2009.03.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
92 Nielsen M, Kaltoft K, Nordahl M, Röpke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A 1997;94:6764-9. [PMID: 9192639 DOI: 10.1073/pnas.94.13.6764] [Cited by in Crossref: 172] [Cited by in F6Publishing: 169] [Article Influence: 6.9] [Reference Citation Analysis]
93 Harris KW, Hu X, Schultz S, Arcasoy MO, Forget BG, Clare N. The Distal Cytoplasmic Domain of the Erythropoietin Receptor Induces Granulocytic Differentiation in 32D Cells. Blood 1998;92:1219-24. [DOI: 10.1182/blood.v92.4.1219.416k07_1219_1224] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
94 Zhang SP, Wang Z, Wang LX, Liu SJ. AG490: An inhibitor of hepcidin expression in vivoWorld J Gastroenterol 2011; 17(45): 5032-5034 [PMID: 22174555 DOI: 10.3748/wjg.v17.i45.5032] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
95 Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, Yamaguchi K, Takatsuki K, Kamihira S, White JD, Leonard WJ, Waldmann T, Franchini G. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci U S A 1997;94:13897-902. [PMID: 9391124 DOI: 10.1073/pnas.94.25.13897] [Cited by in Crossref: 194] [Cited by in F6Publishing: 199] [Article Influence: 8.1] [Reference Citation Analysis]
96 Abe J, Berk BC. Fyn and JAK2 Mediate Ras Activation by Reactive Oxygen Species. Journal of Biological Chemistry 1999;274:21003-10. [DOI: 10.1074/jbc.274.30.21003] [Cited by in Crossref: 147] [Cited by in F6Publishing: 137] [Article Influence: 6.4] [Reference Citation Analysis]
97 Forster AH, Wang MM, Butler WF, Chachisvilis M, Chung TD, Esener SC, Hall JM, Kibar O, Lykstad K, Marchand PJ, Mercer EM, Pestana LM, Sur S, Tu E, Yang R, Zhang H, Kariv I. Use of moving optical gradient fields for analysis of apoptotic cellular responses in a chronic myeloid leukemia cell model. Analytical Biochemistry 2004;327:14-22. [DOI: 10.1016/j.ab.2003.12.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
98 Puthier D, Bataille R, Amiot M. IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway. Eur J Immunol 1999;29:3945-50. [PMID: 10602002 DOI: 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O] [Cited by in Crossref: 192] [Cited by in F6Publishing: 69] [Article Influence: 8.7] [Reference Citation Analysis]
99 Velloso FJ, Bianco AF, Farias JO, Torres NE, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG. The crossroads of breast cancer progression: insights into the modulation of major signaling pathways. Onco Targets Ther 2017;10:5491-524. [PMID: 29200866 DOI: 10.2147/OTT.S142154] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
100 Zeng Y, Min L, Han Y, Meng L, Liu C, Xie Y, Dong B, Wang L, Jiang B, Xu H, Zhuang Q, Zhao C, Qu L, Shou C. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis. Carcinogenesis 2014;35:2244-53. [DOI: 10.1093/carcin/bgu132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
101 Chen Y, Deng J, Fujimoto J, Kadara H, Men T, Lotan D, Lotan R. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor. Cancer Res 2010;70:8917-26. [PMID: 20959490 DOI: 10.1158/0008-5472.CAN-10-0518] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
102 Neeli I, Liu Z, Dronadula N, Ma ZA, Rao GN. An essential role of the Jak-2/STAT-3/cytosolic phospholipase A(2) axis in platelet-derived growth factor BB-induced vascular smooth muscle cell motility. J Biol Chem 2004;279:46122-8. [PMID: 15322111 DOI: 10.1074/jbc.M406922200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
103 Agarwal C, Tyagi A, Kaur M, Agarwal R. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis 2007;28:1463-70. [PMID: 17341659 DOI: 10.1093/carcin/bgm042] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 5.8] [Reference Citation Analysis]
104 Yellaturu CR, Rao GN. Cytosolic phospholipase A2 is an effector of Jak/STAT signaling and is involved in platelet-derived growth factor BB-induced growth in vascular smooth muscle cells. J Biol Chem. 2003;278:9986-9992. [PMID: 12529382 DOI: 10.1074/jbc.m211276200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
105 Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 2001;28:29-35. [PMID: 11326271 DOI: 10.1038/ng0501-29] [Cited by in Crossref: 253] [Cited by in F6Publishing: 352] [Article Influence: 12.0] [Reference Citation Analysis]
106 Gesbert F, Delespine-Carmagnat M, Bertoglio J. Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol 1998;18:307-20. [PMID: 9793823 DOI: 10.1023/a:1023223614407] [Cited by in Crossref: 58] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
107 Cao Q, Mak KM, Ren C, Lieber CS. Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells. Journal of Biological Chemistry 2004;279:4292-304. [DOI: 10.1074/jbc.m308351200] [Cited by in Crossref: 121] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
108 Foshay K, Rodriguez G, Hoel B, Narayan J, Gallicano GI. JAK2/STAT3 directs cardiomyogenesis within murine embryonic stem cells in vitro. Stem Cells 2005;23:530-43. [PMID: 15790774 DOI: 10.1634/stemcells.2004-0293] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 3.5] [Reference Citation Analysis]
109 Tuyt LM, Bregman K, Lummen C, Dokter WH, Vellenga E. Differential Binding Activity of the Transcription Factor LIL-Stat in Immature and Differentiated Normal and Leukemic Myeloid Cells. Blood 1998;92:1364-73. [DOI: 10.1182/blood.v92.4.1364] [Cited by in Crossref: 14] [Article Influence: 0.6] [Reference Citation Analysis]
110 Ho Y, Tsao S, Zeng M, Lui VWY. STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma. Cancer Letters 2013;330:141-9. [DOI: 10.1016/j.canlet.2012.11.052] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
111 Han M, Li AY, Meng F, Dong LH, Zheng B, Hu HJ, Nie L, Wen JK. Synergistic co-operation of signal transducer and activator of transcription 5B with activator protein 1 in angiotensin II-induced angiotensinogen gene activation in vascular smooth muscle cells. FEBS J 2009;276:1720-8. [PMID: 19220857 DOI: 10.1111/j.1742-4658.2009.06902.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
112 von Lindern M, Amelsvoort MP, van Dijk T, Deiner E, van den Akker E, van Emst-de Vries S, Willems P, Beug H, Löwenberg B. Protein Kinase C α Controls Erythropoietin Receptor Signaling. Journal of Biological Chemistry 2000;275:34719-27. [DOI: 10.1074/jbc.m007042200] [Cited by in Crossref: 60] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
113 Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J. 2000;14:2329-2338. [PMID: 11053255 DOI: 10.1096/fj.00-0162] [Cited by in Crossref: 173] [Cited by in F6Publishing: 170] [Article Influence: 7.9] [Reference Citation Analysis]
114 Kumano K, Nakao A, Nakajima H, Miike S, Kurasawa K, Saito Y, Iwamoto I. Blockade of JAK2 by Tyrphostin AG-490 Inhibits Antigen-Induced Eosinophil Recruitment into the Mouse Airways. Biochemical and Biophysical Research Communications 2000;270:209-14. [DOI: 10.1006/bbrc.2000.2403] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
115 Ikeda Y, Takeuchi K, Kato T, Taniyama Y, Sato K, Takahashi N, Sugawara A, Ito S. Transcriptional Suppression of Rat Angiotensin AT1a Receptor Gene Expression by Interferon-γ in Vascular Smooth Muscle Cells. Biochemical and Biophysical Research Communications 1999;262:494-8. [DOI: 10.1006/bbrc.1999.1226] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
116 Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J, Grandis JR. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 2003;278:31574-83. [PMID: 12771142 DOI: 10.1074/jbc.M303499200] [Cited by in Crossref: 134] [Cited by in F6Publishing: 65] [Article Influence: 7.1] [Reference Citation Analysis]
117 Wilbanks AM, Mahajan S, Frank DA, Druker BJ, Gilliland D, Carroll M. TEL/PDGFβR fusion protein activates STAT1 and STAT5. Experimental Hematology 2000;28:584-93. [DOI: 10.1016/s0301-472x(00)00138-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
118 Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, Heinrich PC, Diehl V, Tesch H. STAT3 is constitutively activated in Hodgkin cell lines. Blood 2001;98:762-70. [DOI: 10.1182/blood.v98.3.762] [Cited by in Crossref: 149] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
119 Sun X, Layton JE, Elefanty A, Lieschke GJ. Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL--expressing cells, demonstrating synergy between AG490 and STI571. Blood 2001;97:2008-15. [PMID: 11264165 DOI: 10.1182/blood.v97.7.2008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
120 Stankoff B, Aigrot MS, Noël F, Wattilliaux A, Zalc B, Lubetzki C. Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci 2002;22:9221-7. [PMID: 12417647 [PMID: 12417647 DOI: 10.1523/jneurosci.22-21-09221.2002] [Reference Citation Analysis]
121 Cohen P. The development and therapeutic potential of protein kinase inhibitors. Current Opinion in Chemical Biology 1999;3:459-65. [DOI: 10.1016/s1367-5931(99)80067-2] [Cited by in Crossref: 131] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
122 Zheng P, Wang W, Ji M, Zhu Q, Feng Y, Zhou F, He Q. TMEM119 promotes gastric cancer cell migration and invasion through STAT3 signaling pathway. Onco Targets Ther 2018;11:5835-44. [PMID: 30271166 DOI: 10.2147/OTT.S164045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
123 Levy O, Ruvinov E, Reem T, Granot Y, Cohen S. Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling. Int J Biochem Cell Biol 2010;42:1823-30. [PMID: 20691278 DOI: 10.1016/j.biocel.2010.07.017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
124 Gonsky R, Deem RL, Landers CJ, Derkowski CA, Berel D, McGovern DP, Targan SR. Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens. Inflamm Bowel Dis. 2011;17:171-178. [PMID: 20848535 DOI: 10.1002/ibd.21352] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
125 Gomez-bougie P, Bataille R, Amiot M. The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells. Eur J Immunol 2004;34:3156-64. [DOI: 10.1002/eji.200424981] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
126 Rui H, Xu J, Mehta S, Fang H, Williams J, Dong F, Grimley PM. Activation of the Jak2-Stat5 Signaling Pathway in Nb2 Lymphoma Cells by an Anti-apoptotic Agent, Aurintricarboxylic Acid. Journal of Biological Chemistry 1998;273:28-32. [DOI: 10.1074/jbc.273.1.28] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
127 Wu KJ, Huang JM, Zhong HJ, Dong ZZ, Vellaisamy K, Lu JJ, Chen XP, Chiu P, Kwong DWJ, Han QB, Ma DL, Leung CH. A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells. PLoS One 2017;12:e0177123. [PMID: 28570563 DOI: 10.1371/journal.pone.0177123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
128 O'Shea JJ, Visconti R, Cheng TP, Gadina M. Jaks and stats as therapeutic targets. Ann Rheum Dis 2000;59 Suppl 1:i115-8. [PMID: 11053101 DOI: 10.1136/ard.59.suppl_1.i115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
129 Cull V, Tilbrook PA, Adenan AS, Chappell D, Ingley E, Sarna MK, Palmer TN, Watowich SS, Klinken SP. Dominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivo. Oncogene 2000;19:953-60. [DOI: 10.1038/sj.onc.1203370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
130 Tyner JW, Walters DK, Willis SG, Luttropp M, Oost J, Loriaux M, Erickson H, Corbin AS, O'Hare T, Heinrich MC, Deininger MW, Druker BJ. RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood 2008;111:2238-45. [PMID: 18025156 DOI: 10.1182/blood-2007-06-097253] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
131 de Groot RP, van Dijk TB, Caldenhoven E, Coffer PJ, Raaijmakers JA, Lammers JW, Koenderman L. Activation of 12-O-tetradecanoylphorbol-13-acetate response element- and dyad symmetry element-dependent transcription by interleukin-5 is mediated by Jun N-terminal kinase/stress-activated protein kinase kinases. J Biol Chem 1997;272:2319-25. [PMID: 8999940 DOI: 10.1074/jbc.272.4.2319] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
132 Bednarek I, Sypniewski D, Gawlik N, Galilejczyk A, Goraus K. The efficiency of silencing expression of the gene coding STAT3 transcriptional factor and susceptibility of bladder cancer cells to apoptosis. Contemp Oncol (Pozn) 2012;16:316-21. [PMID: 23788901 DOI: 10.5114/wo.2012.30060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Tessier C, Prigent-Tessier A, Ferguson-Gottschall S, Gu Y, Gibori G. PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity. Endocrinology 2001;142:4086-94. [PMID: 11517188 DOI: 10.1210/endo.142.9.8381] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
134 Liu R, Liu C, Mohi MG, Arai K, Watanabe S. Analysis of mechanisms involved in the prevention of γ irradiation-induced apoptosis by hGM-CSF. Oncogene 2000;19:571-9. [DOI: 10.1038/sj.onc.1203364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
135 McIntosh MT, Koganti S, Boatwright JL, Li X, Spadaro SV, Brantly AC, Ayers JB, Perez RD, Burton EM, Burgula S, MacCarthy T, Bhaduri-McIntosh S. STAT3 imparts BRCAness by impairing homologous recombination repair in Epstein-Barr virus-transformed B lymphocytes. PLoS Pathog 2020;16:e1008849. [PMID: 33002095 DOI: 10.1371/journal.ppat.1008849] [Reference Citation Analysis]
136 Collins J. Phage display. In: Moos WH, Pavia MR, Kay BK, Ellington AD, editors. Annual Reports in Combinatorial Chemistry and Molecular Diversity. Dordrecht: Springer Netherlands; 1997. pp. 210-62. [DOI: 10.1007/978-0-306-46904-6_15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
137 Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F. Constitutive activation of STAT transcription factors in acute myelogenous leukemia. Eur J Haematol. 2001;67:63-71. [PMID: 11722592 DOI: 10.1034/j.1600-0609.2001.t01-1-00385.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
138 Andrianifahanana M, Singh AP, Nemos C, Ponnusamy MP, Moniaux N, Mehta PP, Varshney GC, Batra SK. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response. Oncogene 2007;26:7251-61. [PMID: 17525742 DOI: 10.1038/sj.onc.1210532] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
139 Draut H, Rehm T, Begemann G, Schobert R. Antiangiogenic and Toxic Effects of Genistein, Usnic Acid, and Their Copper Complexes in Zebrafish Embryos at Different Developmental Stages. Chem Biodivers 2017;14. [PMID: 27936296 DOI: 10.1002/cbdv.201600302] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
140 Lifshitz L, Prutchi-sagiv S, Avneon M, Gassmann M, Mittelman M, Neumann D. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells. Molecular Immunology 2009;46:713-21. [DOI: 10.1016/j.molimm.2008.10.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
141 Herencia C, Almadén Y, Ferrín G, Martínez-romero R, de la Mata M, Ciria R, Briceño FJ, Muñoz-castañeda JR. Cardiotrophin-1 decreases liver apoptosis through calpastatin induction. Journal of Surgical Research 2015;193:119-25. [DOI: 10.1016/j.jss.2014.06.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
142 Verstovsek S, Quintás-Cardama A, Kantarjian H, Tefferi A. Experimental therapy in myelofibrosis with myeloid metaplasia. Expert Opin Investig Drugs 2006;15:1555-63. [PMID: 17107281 DOI: 10.1517/13543784.15.12.1555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
143 Matozaki M, Saito Y, Yasutake R, Munira S, Kaibori Y, Yukawa A, Tada M, Nakayama Y. Involvement of Stat3 phosphorylation in mild heat shock-induced thermotolerance. Exp Cell Res 2019;377:67-74. [PMID: 30776355 DOI: 10.1016/j.yexcr.2019.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
144 Muscella A, Vetrugno C, Marsigliante S. CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture. Mol Carcinog 2017;56:2461-73. [PMID: 28618084 DOI: 10.1002/mc.22693] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
145 Yi F, Merrill BJ. Non-cell-autonomous stimulation of stem cell proliferation following ablation of Tcf3. Exp Cell Res 2010;316:1050-60. [PMID: 20006604 DOI: 10.1016/j.yexcr.2009.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
146 Benekli M, Baumann H, Wetzler M. Targeting signal transducer and activator of transcription signaling pathway in leukemias. J Clin Oncol 2009;27:4422-32. [PMID: 19667270 DOI: 10.1200/JCO.2008.21.3264] [Cited by in Crossref: 95] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
147 De Vos J, Jourdan M, Tarte K, Jasmin C, Klein B. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br J Haematol 2000;109:823-8. [PMID: 10929036 DOI: 10.1046/j.1365-2141.2000.02127.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 121] [Article Influence: 5.6] [Reference Citation Analysis]
148 Piccardoni P, Sideri R, Manarini S, Piccoli A, Martelli N, de Gaetano G, Cerletti C, Evangelista V. Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood 2001;98:108-16. [DOI: 10.1182/blood.v98.1.108] [Cited by in Crossref: 74] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
149 Levitzki A. Targeting signal transduction for disease therapy. Current Opinion in Cell Biology 1996;8:239-44. [DOI: 10.1016/s0955-0674(96)80071-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
150 Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001;107:351-362. [PMID: 11160159 DOI: 10.1172/jci9940] [Cited by in Crossref: 424] [Cited by in F6Publishing: 215] [Article Influence: 20.2] [Reference Citation Analysis]
151 Zhang H, Zhu D, Li Z, Sun J, Zhu H. Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents. Bioorganic & Medicinal Chemistry 2011;19:4513-9. [DOI: 10.1016/j.bmc.2011.06.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
152 Cruz MT, Duarte CB, Gonçalo M, Carvalho AP, Lopes MC. LPS induction of I kappa B-alpha degradation and iNOS expression in a skin dendritic cell line is prevented by the janus kinase 2 inhibitor, Tyrphostin b42. Nitric Oxide 2001;5:53-61. [PMID: 11178937 DOI: 10.1006/niox.2000.0320] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
153 Tao Y, Han J, Liu W, An L, Hu W, Wang N, Yu Y. MUC1 Promotes Mesangial Cell Proliferation and Kidney Fibrosis in Diabetic Nephropathy Through Activating STAT and β-Catenin Signal Pathway. DNA Cell Biol 2021;40:1308-16. [PMID: 34520253 DOI: 10.1089/dna.2021.0098] [Reference Citation Analysis]
154 Burger R, Bakker F, Guenther A, Baum W, Schmidt-arras D, Hideshima T, Tai Y, Shringarpure R, Catley L, Senaldi G, Gramatzki M, Anderson KC. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival: NNT-1/BSF-3 in Multiple Myeloma. British Journal of Haematology 2003;123:869-78. [DOI: 10.1046/j.1365-2141.2003.04686.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
155 Rebouissou C, Wijdenes J, Autissier P, Tarte K, Costes V, Liautard J, Rossi J, Brochier J, Klein B. A gp130 Interleukin-6 Transducer-Dependent SCID Model of Human Multiple Myeloma. Blood 1998;91:4727-37. [DOI: 10.1182/blood.v91.12.4727.412k35_4727_4737] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
156 Ochiai K, Tanabe E, Ishihara C, Kagami M, Sugiyama T, Sueishi M, Koya N, Tomioka H. Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma). Clin Exp Immunol 1999;118:340-3. [PMID: 10594549 DOI: 10.1046/j.1365-2249.1999.01068.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
157 Ying H, Xu MC, Tan JH, Shen JH, Wang H, Zhang DF. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling. Int J Mol Sci 2014;15:20240-53. [PMID: 25380525 DOI: 10.3390/ijms151120240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
158 Ceyzériat K, Abjean L, Carrillo-de Sauvage M, Ben Haim L, Escartin C. The complex STATes of astrocyte reactivity: How are they controlled by the JAK–STAT3 pathway? Neuroscience 2016;330:205-18. [DOI: 10.1016/j.neuroscience.2016.05.043] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
159 Ball S, Li C, Li PK, Lin J. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells. PLoS One 2011;6:e18820. [PMID: 21526200 DOI: 10.1371/journal.pone.0018820] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
160 Huang C, Yang G, Jiang T, Cao J, Huang KJ, Qiu ZJ. Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth. World J Gastroenterol 2011; 17(25): 2992-3001 [PMID: 21799645 DOI: 10.3748/wjg.v17.i25.2992] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
161 Gonsky R, Deem RL, Bream J, Young HA, Targan SR. Enhancer role of STAT5 in CD2 activation of IFN-gamma gene expression. J Immunol 2004;173:6241-7. [PMID: 15528362 DOI: 10.4049/jimmunol.173.10.6241] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
162 Lee S, Duhé RJ. Kinase activity and subcellular distribution of a chimeric green fluorescent protein-tagged Janus kinase 2. J Biomed Sci 2006;13:773-86. [PMID: 16972141 DOI: 10.1007/s11373-006-9111-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
163 Fatih N, Camberlein E, Island ML, Corlu A, Abgueguen E, Détivaud L, Leroyer P, Brissot P, Loréal O. Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form. J Mol Med (Berl). 2010;88:477-486. [PMID: 20169331 DOI: 10.1007/s00109-009-0588-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
164 Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett. 2010;292:197-207. [PMID: 20053498 DOI: 10.1016/j.canlet.2009.12.003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 9.8] [Reference Citation Analysis]
165 Bromberg J. Stat proteins and oncogenesis. J Clin Invest. 2002;109:1139-1142. [PMID: 11994401 DOI: 10.1172/jci0215617] [Cited by in Crossref: 540] [Cited by in F6Publishing: 1] [Article Influence: 27.0] [Reference Citation Analysis]
166 Li ZY, Chao HH, Liu HY, Song ZH, Li LL, Zhang YJ, Yang Y, Peng JP. IFN-γ induces aberrant CD49b⁺ NK cell recruitment through regulating CX3CL1: a novel mechanism by which IFN-γ provokes pregnancy failure. Cell Death Dis 2014;5:e1512. [PMID: 25375377 DOI: 10.1038/cddis.2014.470] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
167 Li R, Pourpak A, Morris SW. Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach. J Med Chem 2009;52:4981-5004. [PMID: 19610618 DOI: 10.1021/jm9002395] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
168 Yokoyama N, Reich NC, Todd Miller W. Determinants for the interaction between Janus kinase 2 and protein phosphatase 2A. Archives of Biochemistry and Biophysics 2003;417:87-95. [DOI: 10.1016/s0003-9861(03)00333-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
169 Shi W, Yan D, Zhao C, Xiao M, Wang Y, Ma H, Liu T, Qin H, Zhang C, Li C, Lin J, Li S, Lv J, Lin L. Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista. Biochem Biophys Res Commun 2017;491:159-65. [PMID: 28711499 DOI: 10.1016/j.bbrc.2017.07.067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
170 Lefler D, Mukhin YV, Pettus T, Leeb-Lundberg LM, Garnovskaya MN, Raymond JR. Jak2 and Ca2+/calmodulin are key intermediates for bradykinin B2 receptor-mediated activation of Na+/H+ exchange in KNRK and CHO cells. Assay Drug Dev Technol 2003;1:281-9. [PMID: 15090193 DOI: 10.1089/15406580360545099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
171 Higuchi T, Shiraishi T, Shirakusa T, Hirayama S, Shibaguchi H, Kuroki M, Hiratuka M, Yamamoto S, Iwasaki A, Kuroki M. Prevention of acute lung allograft rejection in rat by the janus kinase 3 inhibitor, tyrphostin AG490. J Heart Lung Transplant 2005;24:1557-64. [PMID: 16210130 DOI: 10.1016/j.healun.2004.11.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
172 Turpaev K, Drapier J. Stimulatory effect of benzylidenemalononitrile tyrphostins on expression of NO-dependent genes in U-937 monocytic cells. European Journal of Pharmacology 2009;606:1-8. [DOI: 10.1016/j.ejphar.2009.01.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
173 Chakilam S, Gandesiri M, Rau TT, Agaimy A, Vijayalakshmi M, Ivanovska J, Wirtz RM, Schulze-Luehrmann J, Benderska N, Wittkopf N, Chellappan A, Ruemmele P, Vieth M, Rave-Fränk M, Christiansen H, Hartmann A, Neufert C, Atreya R, Becker C, Steinberg P, Schneider-Stock R. Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. Am J Pathol 2013;182:1005-20. [PMID: 23438478 DOI: 10.1016/j.ajpath.2012.11.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
174 Hashioka S, Klegeris A, Qing H, McGeer PL. STAT3 inhibitors attenuate interferon-γ-induced neurotoxicity and inflammatory molecule production by human astrocytes. Neurobiol Dis 2011;41:299-307. [PMID: 20888416 DOI: 10.1016/j.nbd.2010.09.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
175 Manshouri T, Quintás-Cardama A, Nussenzveig RH, Gaikwad A, Estrov Z, Prchal J, Cortes JE, Kantarjian HM, Verstovsek S. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation. Cancer Sci 2008;99:1265-73. [PMID: 18482053 DOI: 10.1111/j.1349-7006.2008.00817.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
176 Ying WZ, Li X, Rangarajan S, Feng W, Curtis LM, Sanders PW. Immunoglobulin light chains generate proinflammatory and profibrotic kidney injury. J Clin Invest 2019;129:2792-806. [PMID: 31205024 DOI: 10.1172/JCI125517] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
177 Jatiani SS, Cosenza SC, Reddy MV, Ha JH, Baker SJ, Samanta AK, Olnes MJ, Pfannes L, Sloand EM, Arlinghaus RB, Reddy EP. A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition. Genes Cancer 2010;1:331-45. [PMID: 20717479 DOI: 10.1177/1947601910371337] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
178 Gu Y, Mohammad IS, Liu Z. Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors. Oncol Lett 2020;19:2585-94. [PMID: 32218808 DOI: 10.3892/ol.2020.11394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
179 Catlett-falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-luna JL, Nuñez G, Dalton WS, Jove R. Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells. Immunity 1999;10:105-15. [DOI: 10.1016/s1074-7613(00)80011-4] [Cited by in Crossref: 1166] [Cited by in F6Publishing: 455] [Article Influence: 50.7] [Reference Citation Analysis]
180 Geirsson JK, Jonsson S, Valgeirsson J. Synthesis and antitumor activity of bicyclo[3.3.1]nonenol derivatives. Bioorganic & Medicinal Chemistry 2004;12:5563-9. [DOI: 10.1016/j.bmc.2004.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
181 Mortaz E, Redegeld FA, Bloksma N, Dunsmore K, Denenberg A, Wong HR, Nijkamp FP, Engels F. Induction of HSP70 is dispensable for anti-inflammatory action of heat shock or NSAIDs in mast cells. Experimental Hematology 2006;34:414-23. [DOI: 10.1016/j.exphem.2005.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
182 Niemi JP, DeFrancesco-Lisowitz A, Cregg JM, Howarth M, Zigmond RE. Overexpression of the monocyte chemokine CCL2 in dorsal root ganglion neurons causes a conditioning-like increase in neurite outgrowth and does so via a STAT3 dependent mechanism. Exp Neurol 2016;275 Pt 1:25-37. [PMID: 26431741 DOI: 10.1016/j.expneurol.2015.09.018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
183 Shaw S, Bencherif M, Marrero MB. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1. J Neurosci 2003;23:11224-8. [PMID: 14657181 [PMID: 14657181 DOI: 10.1523/jneurosci.23-35-11224.2003] [Cited by in Crossref: 23] [Article Influence: 1.2] [Reference Citation Analysis]
184 Sedlacek HH. Kinase inhibitors in cancer therapy: a look ahead. Drugs 2000;59:435-76. [PMID: 10776829 DOI: 10.2165/00003495-200059030-00004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
185 Liang W, Hague B, Zhao T, Kindt TJ. HTLV-1 Cell Lines Differ in Constitutively Activated Signaling Pathways That Can Be Altered by Cytokine Exposure. Virology 2001;290:91-8. [DOI: 10.1006/viro.2001.1156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
186 Campbell GS, Yu C, Jove R, Carter-su C. Constitutive Activation of JAK1 in Src-transformed Cells. Journal of Biological Chemistry 1997;272:2591-4. [DOI: 10.1074/jbc.272.5.2591] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 2.7] [Reference Citation Analysis]
187 Sternberg DW, Gilliland DG. The Role of Signal Transducer and Activator of Transcription Factors in Leukemogenesis. JCO 2004;22:361-71. [DOI: 10.1200/jco.2004.10.124] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
188 McGregor G, Clements L, Farah A, Irving AJ, Harvey J. Age-dependent regulation of excitatory synaptic transmission at hippocampal temporoammonic-CA1 synapses by leptin. Neurobiol Aging 2018;69:76-93. [PMID: 29860205 DOI: 10.1016/j.neurobiolaging.2018.05.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
189 Okazaki Takahashi M, Takahashi Y, Iida K, Okimura Y, Kaji H, Abe H, Chihara K. Growth Hormone Stimulates Tyrosine Phosphorylation of Focal Adhesion Kinase (p125FAK) and Actin Stress Fiber Formation in Human Osteoblast-like Cells, Saos2. Biochemical and Biophysical Research Communications 1999;263:100-6. [DOI: 10.1006/bbrc.1999.1314] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
190 Sayyah J, Magis A, Ostrov DA, Allan RW, Braylan RC, Sayeski PP. Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. Mol Cancer Ther 2008;7:2308-18. [PMID: 18723478 DOI: 10.1158/1535-7163.MCT-08-0279] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
191 Breggia AC, Wojchowski DM, Himmelfarb J. JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells. Am J Physiol Renal Physiol. 2008;295:F1689-F1695. [PMID: 18815218 DOI: 10.1152/ajprenal.90333.2008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
192 Luo Y, Qiu KM, Lu X, Liu K, Fu J, Zhu HL. Synthesis, biological evaluation, and molecular modeling of cinnamic acyl sulfonamide derivatives as novel antitubulin agents. Bioorg Med Chem 2011;19:4730-8. [PMID: 21783370 DOI: 10.1016/j.bmc.2011.06.088] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
193 Bao L, Devi YS, Bowen-Shauver J, Ferguson-Gottschall S, Robb L, Gibori G. The role of interleukin-11 in pregnancy involves up-regulation of alpha2-macroglobulin gene through janus kinase 2-signal transducer and activator of transcription 3 pathway in the decidua. Mol Endocrinol 2006;20:3240-50. [PMID: 16959875 DOI: 10.1210/me.2006-0296] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
194 Demin P, Rounova O, Grunberger T, Cimpean L, Sharfe N, Roifman CM. Tyrenes: synthesis of new antiproliferative compounds with an extended conjugation. Bioorg Med Chem 2004;12:3019-26. [PMID: 15142560 DOI: 10.1016/j.bmc.2004.03.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
195 Terra LF, Garay-malpartida MH, Wailemann RAM, Sogayar MC, Labriola L. Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways. Diabetologia 2011;54:1388-97. [DOI: 10.1007/s00125-011-2102-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
196 Wang LH, Kirken RA, Yang XY, Erwin RA, Dasilva L, Yu C, Farrar WL. Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells. Blood 2000;95:3816-22. [DOI: 10.1182/blood.v95.12.3816.012k29_3816_3822] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
197 Hill ER, Koganti S, Zhi J, Megyola C, Freeman AF, Palendira U, Tangye SG, Farrell PJ, Bhaduri-McIntosh S. Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes. J Virol 2013;87:11438-46. [PMID: 23966384 DOI: 10.1128/JVI.01762-13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
198 Ravandi F, Talpaz M, Kantarjian H, Estrov Z. Cellular signalling pathways: new targets in leukaemia therapy. Br J Haematol 2002;116:57-77. [PMID: 11841398 DOI: 10.1046/j.1365-2141.2002.03236.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
199 O'Shea JJ, Pesu M, Borie DC, Changelian PS. A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat Rev Drug Discov. 2004;3:555-564. [PMID: 15232577 DOI: 10.1038/nrd1441] [Cited by in Crossref: 230] [Cited by in F6Publishing: 210] [Article Influence: 12.8] [Reference Citation Analysis]
200 Naka T, Fujimoto M, Kishimoto T. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem Sci 1999;24:394-8. [PMID: 10500304 DOI: 10.1016/s0968-0004(99)01454-1] [Cited by in Crossref: 86] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
201 Sayeski PP, Ali MS, Hawks K, Frank SJ, Bernstein KE. The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src. Circ Res 1999;84:1332-8. [PMID: 10364571 DOI: 10.1161/01.res.84.11.1332] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
202 Wilks AF. The JAK kinases: not just another kinase drug discovery target. Semin Cell Dev Biol 2008;19:319-28. [PMID: 18721891 DOI: 10.1016/j.semcdb.2008.07.020] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
203 Mologni L, Sala E, Riva B, Cesaro L, Cazzaniga S, Redaelli S, Marin O, Pasquato N, Donella-deana A, Gambacorti-passerini C. Expression, purification, and inhibition of human RET tyrosine kinase. Protein Expression and Purification 2005;41:177-85. [DOI: 10.1016/j.pep.2005.01.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
204 Sulong S, Case M, Minto L, Wilkins B, Hall A, Irving J. The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia. Br J Haematol 2005;130:964-5. [DOI: 10.1111/j.1365-2141.2005.05697.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
205 Kim H. Cerulein pancreatitis: oxidative stress, inflammation, and apoptosis. Gut Liver. 2008;2:74-80. [PMID: 20485614 DOI: 10.5009/gnl.2008.2.2.74] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 4.9] [Reference Citation Analysis]
206 Seo IA, Lee HK, Shin YK, Lee SH, Seo SY, Park JW, Park HT. Janus Kinase 2 Inhibitor AG490 Inhibits the STAT3 Signaling Pathway by Suppressing Protein Translation of gp130. Korean J Physiol Pharmacol. 2009;13:131-138. [PMID: 19885008 DOI: 10.4196/kjpp.2009.13.2.131] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
207 Swiatek-machado K, Mieczkowski J, Ellert-miklaszewska A, Swierk P, Fokt I, Szymanski S, Skora S, Szeja W, Grynkiewicz G, Lesyng B, Priebe W, Kaminska B. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells. Cancer Biology & Therapy 2014;13:657-70. [DOI: 10.4161/cbt.20083] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
208 Goffin V, Touraine P, Pichard C, Bernichtein S, Kelly PA. Should prolactin be reconsidered as a therapeutic target in human breast cancer? Molecular and Cellular Endocrinology 1999;151:79-87. [DOI: 10.1016/s0303-7207(99)00023-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
209 Seidel HM, Lamb P, Rosen J. Pharmaceutical intervention in the JAK/STAT signaling pathway. Oncogene. 2000;19:2645-2656. [PMID: 10851064 DOI: 10.1038/sj.onc.1203550] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 3.0] [Reference Citation Analysis]
210 Cavicchi M, Whittle BJ. Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP. Gut 1999;45:367-74. [PMID: 10446104 DOI: 10.1136/gut.45.3.367] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
211 Lamb P, Rosen J. Minireview: Drug Discovery Using Receptors that Modulate Gene Expression. Journal of Receptors and Signal Transduction 2009;17:531-43. [DOI: 10.3109/10799899709036626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
212 Li Y, Li Z, Zhu WG. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics. Curr Med Chem 2019;26:1328-50. [PMID: 28933282 DOI: 10.2174/0929867324666170921101947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
213 Coluccia AM, Gunby RH, Tartari CJ, Scapozza L, Gambacorti-Passerini C, Passoni L. Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy. Expert Opin Ther Targets 2005;9:515-32. [PMID: 15948671 DOI: 10.1517/14728222.9.3.515] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
214 Luo P, Shi W, Wang Y, Ma H, Liu T, Yan D, Huo S, Guo J, Wang M, Li C, Lin J, Zhang C, Li S, Lv J, Lin L. Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE-/- mice. Life Sci 2020;261:118304. [PMID: 32828944 DOI: 10.1016/j.lfs.2020.118304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
215 Shikano M, Onimura K, Fukai Y, Hori M, Fukazawa H, Mizuno S, Yazawa K, Uehara Y. 1a-Docosahexaenoyl Mitomycin C: A Novel Inhibitor of Protein Tyrosine Kinase. Biochemical and Biophysical Research Communications 1998;248:858-63. [DOI: 10.1006/bbrc.1998.9077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
216 Zhang HH, Kuang S, Wang Y, Sun XX, Gu Y, Hu LH, Yu Q. Bigelovin inhibits STAT3 signaling by inactivating JAK2 and induces apoptosis in human cancer cells. Acta Pharmacol Sin 2015;36:507-16. [PMID: 25619393 DOI: 10.1038/aps.2014.143] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
217 Kajimoto T, Ohmori S, Shirai Y, Sakai N, Saito N. Subtype-specific translocation of the delta subtype of protein kinase C and its activation by tyrosine phosphorylation induced by ceramide in HeLa cells. Mol Cell Biol 2001;21:1769-83. [PMID: 11238914 DOI: 10.1128/MCB.21.5.1769-1783.2001] [Cited by in Crossref: 81] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
218 Grandage VL, Everington T, Linch DC, Khwaja A. Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. Br J Haematol 2006;135:303-16. [PMID: 16956345 DOI: 10.1111/j.1365-2141.2006.06291.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 4.1] [Reference Citation Analysis]
219 Xenaki D, Pierce A, Underhill-Day N, Whetton AD, Owen-Lynch PJ. Bcr-Abl-mediated molecular mechanism for apoptotic suppression in multipotent haemopoietic cells: a role for PKCbetaII. Cell Signal 2004;16:145-56. [PMID: 14636885 DOI: 10.1016/s0898-6568(03)00101-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
220 Lellis-Santos C, Sakamoto LH, Bromati CR, Nogueira TC, Leite AR, Yamanaka TS, Kinote A, Anhê GF, Bordin S. The regulation of Rasd1 expression by glucocorticoids and prolactin controls peripartum maternal insulin secretion. Endocrinology 2012;153:3668-78. [PMID: 22700767 DOI: 10.1210/en.2012-1135] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
221 Aringer M, Cheng A, Nelson JW, Chen M, Sudarshan C, Zhou YJ, O'Shea JJ. Janus kinases and their role in growth and disease. Life Sci. 1999;64:2173-2186. [PMID: 10374907 DOI: 10.1016/s0024-3205(98)00538-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
222 Prigent-tessier A, Barkai U, Tessier C, Cohen H, Gibori G. Characterization of a Rat Uterine Cell Line, UIII Cells: Prolactin (PRL) Expression and Endogenous Regulation of PRL-Dependent Genes; Estrogen Receptor β, α 2-Macroglobulin, and Decidual PRL Involving the Jak2 and Stat5 Pathway*. Endocrinology 2001;142:1242-50. [DOI: 10.1210/endo.142.3.8004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
223 Mohapatra S, Pledger W. Interdependence of cdk2 Activation and Interleukin-2Rα Accumulation in T Cells. Journal of Biological Chemistry 2001;276:21984-9. [DOI: 10.1074/jbc.m100037200] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
224 Neria F, Caramelo C, Peinado H, González-Pacheco FR, Deudero JJ, de Solis AJ, Fernández-Sánchez R, Peñate S, Cano A, Castilla MA. Mechanisms of endothelial cell protection by blockade of the JAK2 pathway. Am J Physiol Cell Physiol 2007;292:C1123-31. [PMID: 17035297 DOI: 10.1152/ajpcell.00548.2005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
225 Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P. Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia. Blood 1997;90:2535-40. [DOI: 10.1182/blood.v90.7.2535.2535_2535_2540] [Cited by in Crossref: 24] [Article Influence: 1.0] [Reference Citation Analysis]
226 Chang NS, Schultz L, Heath J. Suppression of IkappaBalpha expression is necessary for c-Jun N-terminal kinase-mediated enhancement of Fas cytotoxicity. Biochem Biophys Res Commun 2000;274:4-10. [PMID: 10903887 DOI: 10.1006/bbrc.2000.3089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
227 Ferrer B, Suresh H, Santamaria A, Rocha JB, Bowman AB, Aschner M. The antioxidant role of STAT3 in methylmercury-induced toxicity in mouse hypothalamic neuronal GT1-7 cell line. Free Radic Biol Med 2021;171:245-59. [PMID: 34010664 DOI: 10.1016/j.freeradbiomed.2021.05.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, Haroon ZA. Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest. 2002;82:911-918. [PMID: 12118093 DOI: 10.1097/01.lab.0000020415.72863.40] [Cited by in Crossref: 133] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
229 Scott LM. Lymphoid malignancies: Another face to the Janus kinases. Blood Reviews 2013;27:63-70. [DOI: 10.1016/j.blre.2012.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
230 Rebouissou C, Wijdenes J, Autissier P, Tarte K, Costes V, Liautard J, Rossi J, Brochier J, Klein B. A gp130 Interleukin-6 Transducer-Dependent SCID Model of Human Multiple Myeloma. Blood 1998;91:4727-37. [DOI: 10.1182/blood.v91.12.4727] [Cited by in Crossref: 41] [Article Influence: 1.7] [Reference Citation Analysis]
231 Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC. Angiotensin II Induces Transactivation of Two Different Populations of the Platelet-derived Growth Factor β Receptor. Journal of Biological Chemistry 2000;275:15926-32. [DOI: 10.1074/jbc.m909616199] [Cited by in Crossref: 129] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
232 Atallah E, Verstovsek S. Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms. Expert Rev Anticancer Ther 2009;9:663-70. [PMID: 19445582 DOI: 10.1586/era.09.14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
233 Gorina R, Sanfeliu C, Galitó A, Messeguer À, Planas AM. Exposure of glia to pro-oxidant agents revealed selective Stat1 activation by H2O2 and Jak2-independent antioxidant features of the Jak2 inhibitor AG490. Glia 2007;55:1313-24. [DOI: 10.1002/glia.20542] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
234 Woodcock JM, Bagley CJ, Lopez AF. Receptors of the cytokine superfamily: mechanisms of activation and involvement in disease. Baillieres Clin Haematol 1997;10:507-24. [PMID: 9421613 DOI: 10.1016/s0950-3536(97)80023-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
235 Birkenkamp K, Geugien M, Lemmink H, Kruijer W, Vellenga E. Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts. Leukemia 2001;15:1923-31. [DOI: 10.1038/sj.leu.2402317] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 4.9] [Reference Citation Analysis]
236 Chen WD, Yu D, Forman BM, Huang W, Wang YD. Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis. Hepatology 2013;57:656-66. [PMID: 22911633 DOI: 10.1002/hep.26019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
237 Rahbar R, Murooka TT, Hinek AA, Galligan CL, Sassano A, Yu C, Srivastava K, Platanias LC, Fish EN. Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication. J Virol 2006;80:7245-59. [PMID: 16809330 DOI: 10.1128/JVI.00463-06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
238 Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci. 1998;353:583-605. [PMID: 9602534 DOI: 10.1098/rstb.1998.0228] [Cited by in Crossref: 292] [Cited by in F6Publishing: 281] [Article Influence: 12.2] [Reference Citation Analysis]
239 Kim BH, Yi EH, Li YC, Park IC, Park JY, Ye SK. Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling. J Breast Cancer 2019;22:362-74. [PMID: 31598337 DOI: 10.4048/jbc.2019.22.e34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
240 Johnson RL, Huang R, Jadhav A, Southall N, Wichterman J, MacArthur R, Xia M, Bi K, Printen J, Austin CP, Inglese J. A quantitative high-throughput screen for modulators of IL-6 signaling: a model for interrogating biological networks using chemical libraries. Mol Biosyst 2009;5:1039-50. [PMID: 19668870 DOI: 10.1039/b902021g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
241 Ju KD, Lim JW, Kim KH, Kim H. Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-β1 in the pathophysiology of acute pancreatitis. Inflamm Res 2011;60:791-800. [PMID: 21509626 DOI: 10.1007/s00011-011-0335-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
242 Mcgregor G, Irving AJ, Harvey J. Canonical JAK‐STAT signaling is pivotal for long‐term depression at adult hippocampal temporoammonic‐CA1 synapses. FASEB j 2017;31:3449-66. [DOI: 10.1096/fj.201601293rr] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
243 Thompson JE, Cubbon RM, Cummings RT, Wicker LS, Frankshun R, Cunningham BR, Cameron PM, Meinke PT, Liverton N, Weng Y, DeMartino JA. Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 2002;12:1219-23. [PMID: 11934592 DOI: 10.1016/s0960-894x(02)00106-3] [Cited by in Crossref: 210] [Cited by in F6Publishing: 77] [Article Influence: 10.5] [Reference Citation Analysis]
244 Ackerman WE 4th, Rovin BH, Kniss DA. Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells. Biol Reprod 2004;71:2079-86. [PMID: 15329330 DOI: 10.1095/biolreprod.104.030841] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
245 Lee JY, Sullivan KE. Gamma interferon and lipopolysaccharide interact at the level of transcription to induce tumor necrosis factor alpha expression. Infect Immun 2001;69:2847-52. [PMID: 11292697 DOI: 10.1128/IAI.69.5.2847-2852.2001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
246 Iversen PO, Lewis ID, Turczynowicz S, Hasle H, Niemeyer C, Schmiegelow K, Bastiras S, Biondi A, Hughes TP, Lopez AF. Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Prevents Dissemination and Induces Remission of Juvenile Myelomonocytic Leukemia in Engrafted Immunodeficient Mice. Blood 1997;90:4910-7. [DOI: 10.1182/blood.v90.12.4910.4910_4910_4917] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
247 Ito J, Nagayasu Y, Okumura-Noji K, Lu R, Nishida T, Miura Y, Asai K, Kheirollah A, Nakaya S, Yokoyama S. Mechanism for FGF-1 to regulate biogenesis of apoE-HDL in astrocytes. J Lipid Res 2007;48:2020-7. [PMID: 17548887 DOI: 10.1194/jlr.M700188-JLR200] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
248 Pike KA, Tremblay ML. Regulating naïve and memory CD8 T cell homeostasis - a role for protein tyrosine phosphatases: Protein tyrosine phosphatases and T cell homeostasis. FEBS Journal 2013;280:432-44. [DOI: 10.1111/j.1742-4658.2012.08587.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
249 Levitzki A, Klein S. My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer. Proc Natl Acad Sci U S A 2019;116:11579-86. [PMID: 31076554 DOI: 10.1073/pnas.1816012116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 de la Torre P, Díaz-sanjuán T, García-ruiz I, Esteban E, Canga F, Muñoz-yagüe T, Solís-herruzo JA. Interleukin-6 increases rat metalloproteinase-13 gene expression through Janus kinase-2-mediated inhibition of serine/threonine phosphatase-2A. Cellular Signalling 2005;17:427-35. [DOI: 10.1016/j.cellsig.2004.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
251 Shimizu S, Yonezawa R, Hagiwara T, Yoshida T, Takahashi N, Hamano S, Negoro T, Toda T, Wakamori M, Mori Y, Ishii M. Inhibitory effects of AG490 on H2O2-induced TRPM2-mediated Ca2+ entry. European Journal of Pharmacology 2014;742:22-30. [DOI: 10.1016/j.ejphar.2014.08.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
252 Liang H, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J Biol Chem 1999;274:19846-51. [PMID: 10391929 DOI: 10.1074/jbc.274.28.19846] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 3.0] [Reference Citation Analysis]
253 Al-Shami A, Naccache PH. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Involvement of Jak2 in the stimulation of phosphatidylinositol 3-kinase. J Biol Chem 1999;274:5333-8. [PMID: 10026141 DOI: 10.1074/jbc.274.9.5333] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 2.7] [Reference Citation Analysis]
254 Pandey MK, Sung B, Ahn KS, Aggarwal BB. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol. 2009;75:525-533. [PMID: 19103760 DOI: 10.1124/mol.108.052548] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 6.3] [Reference Citation Analysis]
255 Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene. 2000;19:2474-2488. [PMID: 10851046 DOI: 10.1038/sj.onc.1203527] [Cited by in Crossref: 1262] [Cited by in F6Publishing: 1241] [Article Influence: 57.4] [Reference Citation Analysis]
256 Wasik MA, Nowak I, Zhang Q, Shaw LM. Suppression of Proliferation and Phosphorylation of Jak3 and STAT5 in Malignant T-cell Lymphoma Cells By Derivatives of Octylamino-Undecyl-Dimethylxanthine. Leukemia & Lymphoma 2009;28:551-60. [DOI: 10.3109/10428199809058363] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
257 Pecquet C, Diaconu CC, Staerk J, Girardot M, Marty C, Royer Y, Defour JP, Dusa A, Besancenot R, Giraudier S, Villeval JL, Knoops L, Courtoy PJ, Vainchenker W, Constantinescu SN. Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes. Blood 2012;119:4625-35. [PMID: 22378845 DOI: 10.1182/blood-2011-08-372524] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
258 Deb S, Tessier C, Prigent-tessier A, Barkai U, Ferguson-gottschall S, Srivastava RK, Faliszek J, Gibori G. The Expression of Interleukin-6 (IL-6), IL-6 Receptor, and gp130-Kilodalton Glycoprotein in the Rat Decidua and a Decidual Cell Line: Regulation by 17β-Estradiol and Prolactin1. Endocrinology 1999;140:4442-50. [DOI: 10.1210/endo.140.10.7063] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
259 Damera G, Xia B, Ancha HR, Sachdev GP. IL-9 modulated MUC4 gene and glycoprotein expression in airway epithelial cells. Biosci Rep 2006;26:55-67. [PMID: 16779668 DOI: 10.1007/s10540-006-9000-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
260 Ma X, Sayeski PP. Vaccinia virus-mediated high level expression and single step purification of recombinant Jak2 protein. Protein Expr Purif 2004;35:181-9. [PMID: 15135391 DOI: 10.1016/j.pep.2004.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
261 Tse K, Novelli E, Civin C, Bohmer F, Small D. Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor. Leukemia 2001;15:1001-10. [DOI: 10.1038/sj.leu.2402199] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 4.2] [Reference Citation Analysis]
262 Davoodi-Semiromi A, Wasserfall CH, Hassanzadeh A, Cooper-DeHoff RM, Wabitsch M, Atkinson M. Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes. Immunogenetics 2013;65:83-90. [PMID: 23081744 DOI: 10.1007/s00251-012-0659-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Miyamoto N, Sugita K, Goi K, Inukai T, Iijima K, Tezuka T, Kojika S, Nakamura M, Kagami K, Nakazawa S. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome. Leukemia 2001;15:1758-68. [DOI: 10.1038/sj.leu.2402260] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
264 Dessauge F, Hilaly S, Baumgartner M, Blumen B, Werling D, Langsley G. c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes. Oncogene 2005;24:1075-83. [PMID: 15580287 DOI: 10.1038/sj.onc.1208314] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
265 Leung C, Chan DS, Ma VP, Ma D. DNA-Binding Small Molecules as Inhibitors of Transcription Factors: DNA-BINDING SMALL MOLECULES. Med Res Rev 2013;33:823-46. [DOI: 10.1002/med.21266] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
266 Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE, Shanmugam MK, Dai X, Li F, Deivasigamani A. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo. J Biol Chem. 2014;289:34296-34307. [PMID: 25320076 DOI: 10.1074/jbc.m114.601104] [Cited by in Crossref: 97] [Cited by in F6Publishing: 43] [Article Influence: 12.1] [Reference Citation Analysis]
267 Choudhury GG, Ghosh-Choudhury N, Abboud HE. Association and direct activation of signal transducer and activator of transcription1alpha by platelet-derived growth factor receptor. J Clin Invest 1998;101:2751-60. [PMID: 9637709 DOI: 10.1172/JCI1044] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
268 Rivadeneira E, Ferrari M, Jarrett R, Armstrong A, Markham P, Birkebak T, Takemoto S, Johnson-delaney C, Pecon-slattery J, Clark E, Franchini G. A Novel Epstein-Barr Virus-Like Virus, HVMNE, in aMacaca Nemestrina With Mycosis Fungoides. Blood 1999;94:2090-101. [DOI: 10.1182/blood.v94.6.2090.418k28_2090_2101] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
269 Xu J, Cole DC, Chang CB, Ayyad R, Asselin M, Hao W, Gibbons J, Jelinsky SA, Saraf KA, Park K. Inhibition of the Signal Transducer and Activator of Transcription-3 (STAT3) Signaling Pathway by 4-Oxo-1-Phenyl-1,4-Dihydroquinoline-3-Carboxylic Acid Esters. J Med Chem 2008;51:4115-21. [DOI: 10.1021/jm701271y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
270 Al Zaid Siddiquee K, Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 2008;18:254-267. [PMID: 18227858 DOI: 10.1038/cr.2008.18] [Cited by in Crossref: 293] [Cited by in F6Publishing: 282] [Article Influence: 20.9] [Reference Citation Analysis]
271 Liu JF, Deng WW, Chen L, Li YC, Wu L, Ma SR, Zhang WF, Bu LL, Sun ZJ. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer. Mol Carcinog. 2018;57:429-439. [PMID: 29215754 DOI: 10.1002/mc.22767] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
272 Tal N, Shochat C, Geron I, Bercovich D, Izraeli S. Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia. Cell Mol Life Sci 2014;71:365-78. [PMID: 23625073 DOI: 10.1007/s00018-013-1337-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
273 Patrick DR, Heimbrook DC. Protein kinase inhibitors for the treatment of cancer. Drug Discovery Today 1996;1:325-30. [DOI: 10.1016/1359-6446(96)10030-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
274 Gallmeier E, Schäfer C, Moubarak P, Tietz A, Plössl I, Huss R, Göke B, Wagner AC. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells. J Cell Physiol. 2005;203:209-216. [PMID: 15493010 DOI: 10.1002/jcp.20216] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
275 Carvalho G, Lefaucheur C, Cherbonnier C, Métivier D, Chapel A, Pallardy M, Bourgeade MF, Charpentier B, Hirsch F, Kroemer G. Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway. Oncogene 2005;24:737-45. [PMID: 15580299 DOI: 10.1038/sj.onc.1208205] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
276 Abe M, Suzuki K, Inagaki O, Sassa S, Shikama H. A novel MPL point mutation resulting in thrombopoietin-independent activation. Leukemia 2002;16:1500-6. [DOI: 10.1038/sj.leu.2402554] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
277 Peng Z, Pal A, Han D, Wang S, Maxwell D, Levitzki A, Talpaz M, Donato NJ, Bornmann W. Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma. Bioorg Med Chem 2011;19:7194-204. [PMID: 22036213 DOI: 10.1016/j.bmc.2011.09.057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
278 Young PR. Pharmacological Modulation of Cytokine Action and Production through Signaling Pathways. Cytokine & Growth Factor Reviews 1998;9:239-57. [DOI: 10.1016/s1359-6101(98)00011-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
279 Virzì A, Roca Suarez AA, Baumert TF, Lupberger J. Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis. Cold Spring Harb Perspect Med 2020;10:a037366. [PMID: 31501266 DOI: 10.1101/cshperspect.a037366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
280 Hiraguri K, Miike S, Sano H, Kurasawa K, Saito Y, Iwamoto I. Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase inhuman eosinophils. Journal of Allergy and Clinical Immunology 1997;100:S45-9. [DOI: 10.1016/s0091-6749(97)70004-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
281 Jost E, do Ó N, Dahl E, Maintz CE, Jousten P, Habets L, Wilop S, Herman JG, Osieka R, Galm O. Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders. Leukemia 2007;21:505-10. [DOI: 10.1038/sj.leu.2404513] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
282 Pollok RC, Farthing MJ, Bajaj-Elliott M, Sanderson IR, McDonald V. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 2001;120:99-107. [PMID: 11208718 DOI: 10.1053/gast.2001.20907] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 3.6] [Reference Citation Analysis]
283 Simon AR, Takahashi S, Severgnini M, Fanburg BL, Cochran BH. Role of the JAK-STAT pathway in PDGF-stimulated proliferation of human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L1296-304. [PMID: 12003786 DOI: 10.1152/ajplung.00315.2001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 3.6] [Reference Citation Analysis]
284 Neria F, Castilla MA, Sanchez RF, Gonzalez Pacheco FR, Deudero JJ, Calabia O, Tejedor A, Manzarbeitia F, Ortiz A, Caramelo C. Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity. Kidney International 2009;75:227-34. [DOI: 10.1038/ki.2008.487] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
285 Kopantzev Y, Heller M, Swaminathan N, Rudikoff S. IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells. Oncogene 2002;21:6791-800. [DOI: 10.1038/sj.onc.1205815] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
286 Nomura N, Nunes P, Bouley R, Nair AV, Shaw S, Ueda E, Pathomthongtaweechai N, Lu HA, Brown D. High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration. Am J Physiol Cell Physiol 2014;307:C597-605. [PMID: 24944200 DOI: 10.1152/ajpcell.00154.2014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
287 Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK, Lin J. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001;20:7925-34. [PMID: 11753675 DOI: 10.1038/sj.onc.1204990] [Cited by in Crossref: 198] [Cited by in F6Publishing: 181] [Article Influence: 9.9] [Reference Citation Analysis]
288 Holtick U, Vockerodt M, Pinkert D, Schoof N, Stürzenhofecker B, Kussebi N, Lauber K, Wesselborg S, Löffler D, Horn F, Trümper L, Kube D. STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis. Leukemia 2005;19:936-44. [PMID: 15912144 DOI: 10.1038/sj.leu.2403750] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
289 Spangenburg EE, Booth FW. Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. Am J Physiol Cell Physiol 2002;283:C204-11. [PMID: 12055089 DOI: 10.1152/ajpcell.00574.2001] [Cited by in Crossref: 123] [Cited by in F6Publishing: 114] [Article Influence: 6.2] [Reference Citation Analysis]
290 Goureau O, Rhee KD, Yang XJ. Ciliary neurotrophic factor promotes muller glia differentiation from the postnatal retinal progenitor pool. Dev Neurosci 2004;26:359-70. [PMID: 15855765 DOI: 10.1159/000082278] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
291 Han R, Chen B, Smith TJ. Jak2 Dampens the Induction by IL-1β of Prostaglandin Endoperoxide H Synthase 2 Expression in Human Orbital Fibroblasts: Evidence for Divergent Influence on the Prostaglandin E 2 Biosynthetic Pathway. J Immunol 2007;179:7147-56. [DOI: 10.4049/jimmunol.179.10.7147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
292 Zhao JB, Zhang Y, Li GZ, Su XF, Hang CH. Activation of JAK2/STAT pathway in cerebral cortex after experimental traumatic brain injury of rats. Neurosci Lett 2011;498:147-52. [PMID: 21596098 DOI: 10.1016/j.neulet.2011.05.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
293 Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel M, Bernard O, Ghysdael J. TEL-JAK2 transgenic mice develop T-cell leukemia. Blood 2000;95:3891-9. [DOI: 10.1182/blood.v95.12.3891] [Cited by in Crossref: 90] [Article Influence: 4.1] [Reference Citation Analysis]
294 Sethi G, Chatterjee S, Rajendran P, Li F, Shanmugam MK, Wong KF, Kumar AP, Senapati P, Behera AK, Hui KM, Basha J, Natesh N, Luk JM, Kundu TK. Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Mol Cancer 2014;13:66. [PMID: 24655440 DOI: 10.1186/1476-4598-13-66] [Cited by in Crossref: 115] [Cited by in F6Publishing: 112] [Article Influence: 14.4] [Reference Citation Analysis]
295 Catlett-falcone R, Dalton WS, Jove R. STAT proteins as novel targets for cancer therapy: . Current Opinion in Oncology 1999;11:490. [DOI: 10.1097/00001622-199911000-00010] [Cited by in Crossref: 122] [Cited by in F6Publishing: 124] [Article Influence: 5.3] [Reference Citation Analysis]
296 Valdembri D, Serini G, Vacca A, Ribatti D, Bussolino F. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J 2002;16:225-7. [PMID: 11744626 DOI: 10.1096/fj.01-0633fje] [Cited by in Crossref: 88] [Cited by in F6Publishing: 89] [Article Influence: 4.2] [Reference Citation Analysis]
297 Ward AC, Touw I, Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 2000;95:19-29. [DOI: 10.1182/blood.v95.1.19] [Cited by in Crossref: 195] [Article Influence: 8.9] [Reference Citation Analysis]
298 Rocha Viegas L, Hoijman E, Beato M, Pecci A. Mechanisms involved in tissue-specific apopotosis regulated by glucocorticoids. J Steroid Biochem Mol Biol 2008;109:273-8. [PMID: 18424036 DOI: 10.1016/j.jsbmb.2008.03.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
299 Marrero MB, Venema VJ, He H, Caldwell RB, Venema RC. Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells. Biochem Biophys Res Commun 1998;252:508-12. [PMID: 9826561 DOI: 10.1006/bbrc.1998.9678] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
300 Antignani A, Youle RJ. The cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), can deliver Bcl-XL as an extracellular fusion protein to protect cells from apoptosis and retain differentiation induction. J Biol Chem 2007;282:11246-54. [PMID: 17311927 DOI: 10.1074/jbc.M609824200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
301 Sharma P, Chakraborty R, Wang L, Min B, Tremblay ML, Kawahara T, Lambeth JD, Haque SJ. Redox regulation of interleukin-4 signaling. Immunity 2008;29:551-64. [PMID: 18957266 DOI: 10.1016/j.immuni.2008.07.019] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
302 Rivadeneira E, Ferrari M, Jarrett R, Armstrong A, Markham P, Birkebak T, Takemoto S, Johnson-delaney C, Pecon-slattery J, Clark E, Franchini G. A Novel Epstein-Barr Virus-Like Virus, HVMNE, in aMacaca Nemestrina With Mycosis Fungoides. Blood 1999;94:2090-101. [DOI: 10.1182/blood.v94.6.2090] [Cited by in Crossref: 16] [Article Influence: 0.7] [Reference Citation Analysis]
303 Hosler GA, Bash R, Scheuermann RH. Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia. Leukemia 2000;14:1215-24. [PMID: 10914545 DOI: 10.1038/sj.leu.2401814] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
304 Stephanou A, Latchman DS. Opposing actions of STAT-1 and STAT-3. Growth Factors. 2005;23:177-182. [PMID: 16243709 DOI: 10.1080/08977190500178745] [Cited by in Crossref: 110] [Cited by in F6Publishing: 110] [Article Influence: 6.5] [Reference Citation Analysis]
305 Gyurkovska V, Stefanova T, Dimitrova P, Danova S, Tropcheva R, Ivanovska N. Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice. Inflammation. 2014;37:995-1005. [PMID: 24473905 DOI: 10.1007/s10753-014-9820-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
306 Honda S, Sadatomi D, Yamamura Y, Nakashioya K, Tanimura S, Takeda K. WP1066 suppresses macrophage cell death induced by inflammasome agonists independently of its inhibitory effect on STAT3. Cancer Sci 2017;108:520-7. [PMID: 28035720 DOI: 10.1111/cas.13154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
307 Pelletier M, Ratthé C, Girard D. Mechanisms involved in interleukin-15-induced suppression of human neutrophil apoptosis: role of the anti-apoptotic Mcl-1 protein and several kinases including Janus kinase-2, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases-1/2. FEBS Lett 2002;532:164-70. [PMID: 12459483 DOI: 10.1016/s0014-5793(02)03668-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
308 Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, Yao H, Liu X, Ke Y, Si J, Zhou T. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 2010;20:784-793. [PMID: 20548334 DOI: 10.1038/cr.2010.79] [Cited by in Crossref: 249] [Cited by in F6Publishing: 235] [Article Influence: 20.8] [Reference Citation Analysis]
309 Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui M, Das DK. Role of STAT3 in Ischemic Preconditioning. Journal of Molecular and Cellular Cardiology 2001;33:1929-36. [DOI: 10.1006/jmcc.2001.1456] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 6.4] [Reference Citation Analysis]
310 Roberts JL, Lengi A, Brown SM, Chen M, Zhou Y, O'shea JJ, Buckley RH. Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation. Blood 2004;103:2009-18. [DOI: 10.1182/blood-2003-06-2104] [Cited by in Crossref: 93] [Cited by in F6Publishing: 74] [Article Influence: 5.2] [Reference Citation Analysis]
311 Pruvot B, Curé Y, Djiotsa J, Voncken A, Muller M. Developmental defects in zebrafish for classification of EGF pathway inhibitors. Toxicol Appl Pharmacol 2014;274:339-49. [PMID: 24262764 DOI: 10.1016/j.taap.2013.11.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
312 Bhagwat SS, Manning AM, Hoekstra MF, Lewis A. Gene-regulating protein kinases as important anti-inflammatory targets. Drug Discovery Today 1999;4:472-9. [DOI: 10.1016/s1359-6446(99)01402-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
313 Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P. Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia. Blood 1997;90:2535-40. [DOI: 10.1182/blood.v90.7.2535] [Cited by in Crossref: 344] [Article Influence: 13.8] [Reference Citation Analysis]
314 Constantin G, Brocke S, Izikson A, Laudanna C, Butcher EC. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis. Eur J Immunol. 1998;28:3523-3529. [PMID: 9842895 DOI: 10.1002/(SICI)1521-4141(199811)28:11%3C3523::AID-IMMU3523%3E3.0.CO;2-X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria R Jr, Marynen P, Gilliland DG. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J 1998;17:5321-33. [PMID: 9736611 DOI: 10.1093/emboj/17.18.5321] [Cited by in Crossref: 193] [Cited by in F6Publishing: 193] [Article Influence: 8.0] [Reference Citation Analysis]
316 Wang Y, Cai D, Brendel C, Barett C, Erben P, Manley PW, Hochhaus A, Neubauer A, Burchert A. Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation. Blood 2006;109:2147-55. [DOI: 10.1182/blood-2006-08-040022] [Cited by in Crossref: 108] [Cited by in F6Publishing: 106] [Article Influence: 6.8] [Reference Citation Analysis]
317 Fujinaka Y, Takane K, Yamashita H, Vasavada RC. Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation. J Biol Chem 2007;282:30707-17. [PMID: 17728251 DOI: 10.1074/jbc.M702607200] [Cited by in Crossref: 62] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
318 Grunicke H. Molecular basis of targeted chemotherapy: Novel concepts with special reference to the treatment of Hodgkin’s disease. Annals of Oncology 1998;9:s125-8. [DOI: 10.1093/annonc/9.suppl_5.s125] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
319 Mora-Garcia P, Sakamoto KM. Cell signaling defects and human disease. Mol Genet Metab 1999;66:143-71. [PMID: 10066384 DOI: 10.1006/mgme.1998.2798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
320 Heo JY, Kim HJ, Kim SM, Park KR, Park SY, Kim SW, Nam D, Jang HJ, Lee SG, Ahn KS, Kim SH, Shim BS, Choi SH, Ahn KS. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Lett 2011;308:71-80. [PMID: 21565443 DOI: 10.1016/j.canlet.2011.04.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
321 Kleinert H, Euchenhofer C, Fritz G, Ihrig-Biedert I, Förstermann U. Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Br J Pharmacol 1998;123:1716-22. [PMID: 9605580 DOI: 10.1038/sj.bjp.0701782] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
322 Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000;19:2496-504. [DOI: 10.1038/sj.onc.1203486] [Cited by in Crossref: 179] [Cited by in F6Publishing: 166] [Article Influence: 8.1] [Reference Citation Analysis]
323 Whetsell M, Bagriacik EU, Seetharamaiah GS, Prabhakar BS, Klein JR. Neuroendocrine-induced synthesis of bone marrow-derived cytokines with inflammatory immunomodulating properties. Cell Immunol 1999;192:159-66. [PMID: 10087184 DOI: 10.1006/cimm.1998.1444] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
324 Chow JY, Carlstrom K, Barrett KE. Growth hormone reduces chloride secretion in human colonic epithelial cells via EGF receptor and extracellular regulated kinase. Gastroenterology. 2003;125:1114-1124. [PMID: 14517795 DOI: 10.1016/s0016-5085(03)01211-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
325 Fuglesteg BN, Suleman N, Tiron C, Kanhema T, Lacerda L, Andreasen TV, Sack MN, Jonassen AK, Mjøs OD, Opie LH, Lecour S. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol 2008;103:444-53. [PMID: 18500485 DOI: 10.1007/s00395-008-0728-x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
326 Pang M, Ma L, Gong R, Tolbert E, Mao H, Ponnusamy M, Chin YE, Yan H, Dworkin LD, Zhuang S. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int 2010;78:257-68. [PMID: 20520592 DOI: 10.1038/ki.2010.154] [Cited by in Crossref: 179] [Cited by in F6Publishing: 175] [Article Influence: 14.9] [Reference Citation Analysis]
327 Grunberger T, Demin P, Rounova O, Sharfe N, Cimpean L, Dadi H, Freywald A, Estrov Z, Roifman CM. Inhibition of acute lymphoblastic and myeloid leukemias by a novel kinase inhibitor. Blood 2003;102:4153-8. [DOI: 10.1182/blood-2003-03-0860] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
328 Choudhury J, Mirshahi F, Murthy KS, Yager DR, Sanyal AJ. Physiologic concentrations of leptin increase collagen production by non-immortalized human hepatic stellate cells. Metabolism 2006;55:1317-22. [PMID: 16979401 DOI: 10.1016/j.metabol.2006.05.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
329 Nakasato M, Shirakura Y, Ooga M, Iwatsuki M, Ito M, Kageyama S, Sakai S, Nagata M, Aoki F. Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. Biol Reprod 2006;75:508-17. [PMID: 16775227 DOI: 10.1095/biolreprod.105.047860] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
330 Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene 2001;20:6643-50. [PMID: 11641791 DOI: 10.1038/sj.onc.1204807] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 3.0] [Reference Citation Analysis]
331 Krumenacker JS, Narang VS, Buckley DJ, Buckley AR. Prolactin signaling to pim-1 expression: a role for phosphatidylinositol 3-kinase. Journal of Neuroimmunology 2001;113:249-59. [DOI: 10.1016/s0165-5728(00)00430-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
332 Liao J, Humphrey SE, Poston S, Taparowsky EJ. Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells. Mol Cancer Res 2011;9:350-63. [PMID: 21296860 DOI: 10.1158/1541-7786.MCR-10-0375] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
333 Tan SM, Li F, Rajendran P, Kumar AP, Hui KM, Sethi G. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. J Pharmacol Exp Ther. 2010;334:285-293. [PMID: 20378717 DOI: 10.1124/jpet.110.165498] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 8.8] [Reference Citation Analysis]
334 Fang Z, Xing F, Bronner C, Teng Z, Guo Z. ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells. Cell Immunol 2009;257:80-7. [PMID: 19328461 DOI: 10.1016/j.cellimm.2009.03.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
335 Abramson HN. Kinase inhibitors as potential agents in the treatment of multiple myeloma. Oncotarget 2016;7:81926-68. [PMID: 27655636 DOI: 10.18632/oncotarget.10745] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
336 Luchtefeld M, Drexler H, Schieffer B. Role of Gβ-Subunit in Angiotensin II-Type 1 Receptor Signaling. Biochemical and Biophysical Research Communications 2001;280:756-60. [DOI: 10.1006/bbrc.2000.4222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
337 Chen Q, Gu Y, Zhang S, Deng H. Effects and mechanisms of action of SARI on androgen-independent prostate cancer (DU145) cells. Tumor Biol 2016;37:16141-9. [DOI: 10.1007/s13277-016-5469-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
338 Stadler K, Bierwirth C, Stoenica L, Battefeld A, Reetz O, Mix E, Schuchmann S, Velmans T, Rosenberger K, Bräuer AU, Lehnardt S, Nitsch R, Budt M, Wolff T, Kole MH, Strauss U. Elevation in type I interferons inhibits HCN1 and slows cortical neuronal oscillations. Cereb Cortex 2014;24:199-210. [PMID: 23042740 DOI: 10.1093/cercor/bhs305] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
339 Mayya V, Loew L. STAT module can function as a biphasic amplitude filter. Systems Biology 2005;2:43-52. [DOI: 10.1049/sb:20045037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
340 Zwick E, Hackel PO, Prenzel N, Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci. 1999;20:408-412. [PMID: 10577253 DOI: 10.1016/s0165-6147(99)01373-5] [Cited by in Crossref: 258] [Cited by in F6Publishing: 78] [Article Influence: 11.2] [Reference Citation Analysis]
341 Kapuria V, Levitzki A, Bornmann WG, Maxwell D, Priebe W, Sorenson RJ, Showalter HD, Talpaz M, Donato NJ. A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination. Cell Signal 2011;23:2076-85. [PMID: 21855629 DOI: 10.1016/j.cellsig.2011.08.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
342 Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, Monti E. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Cancer Letters 2007;258:181-8. [DOI: 10.1016/j.canlet.2007.08.019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
343 Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel M, Bernard O, Ghysdael J. TEL-JAK2 transgenic mice develop T-cell leukemia. Blood 2000;95:3891-9. [DOI: 10.1182/blood.v95.12.3891.012k13_3891_3899] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
344 Li L, Shaw PE. Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines. J Biol Chem. 2002;277:17397-17405. [PMID: 11859072 DOI: 10.1074/jbc.m109962200] [Cited by in Crossref: 82] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
345 Lilly MB, Zemskova M, Frankel AE, Salo J, Kraft AS. Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor α subunit mediate activation of Jak/Stat signaling and differentiation. Blood 2001;97:1662-70. [DOI: 10.1182/blood.v97.6.1662] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
346 Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ, Broxmeyer HE. Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J Exp Med 2000;192:719-28. [PMID: 10974037 DOI: 10.1084/jem.192.5.719] [Cited by in Crossref: 152] [Cited by in F6Publishing: 137] [Article Influence: 6.9] [Reference Citation Analysis]
347 Hösel M, Quasdorff M, Ringelhan M, Kashkar H, Debey-Pascher S, Sprinzl MF, Bockmann JH, Arzberger S, Webb D, von Olshausen G, Weber A, Schultze JL, Büning H, Heikenwalder M, Protzer U. Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication. Cell Mol Gastroenterol Hepatol 2017;4:339-63. [PMID: 28884137 DOI: 10.1016/j.jcmgh.2017.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
348 Lin L, Benson DM Jr, DeAngelis S, Bakan CE, Li PK, Li C, Lin J. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells. Int J Cancer 2012;130:1459-69. [PMID: 21520044 DOI: 10.1002/ijc.26152] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
349 Freed DH, Chilton L, Li Y, Dangerfield AL, Raizman JE, Rattan SG, Visen N, Hryshko LV, Dixon IMC. Role of myosin light chain kinase in cardiotrophin-1-induced cardiac myofibroblast cell migration. American Journal of Physiology-Heart and Circulatory Physiology 2011;301:H514-22. [DOI: 10.1152/ajpheart.01041.2010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
350 De Stefano D, Maiuri MC, Iovine B, Ialenti A, Bevilacqua MA, Carnuccio R. The role of NF-κB, IRF-1, and STAT-1α transcription factors in the iNOS gene induction by gliadin and IFN-γ in RAW 264.7 macrophages. J Mol Med 2006;84:65-74. [DOI: 10.1007/s00109-005-0713-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
351 Selvaraj NG, Omi E, Gibori G, Rao MC. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter. Mol Endocrinol 2000;14:2054-65. [PMID: 11117534 DOI: 10.1210/mend.14.12.0568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.1] [Reference Citation Analysis]
352 O'Shea JJ. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 1997;7:1-11. [PMID: 9252115 DOI: 10.1016/s1074-7613(00)80505-1] [Cited by in Crossref: 265] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
353 Lindauer K, Loerting T, Liedl KR, Kroemer RT. Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation. Protein Eng 2001;14:27-37. [PMID: 11287676 DOI: 10.1093/protein/14.1.27] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 6.0] [Reference Citation Analysis]
354 Liang M, Ma Q, Ding N, Luo F, Bai Y, Kang F, Gong X, Dong R, Dai J, Dai Q, Dou C, Dong S. IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis. Cell Death Dis 2019;10:353. [PMID: 31040267 DOI: 10.1038/s41419-019-1594-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
355 Koschmieder S, Hofmann W, Kunert J, Wagner S, Ballas K, Seipelt G, Hoelzer D, Ottmann O, Kalina U. TGFβ-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS. Leukemia 2001;15:942-9. [DOI: 10.1038/sj.leu.2402119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
356 Dillon M, Minear J, Johnson J, Lannutti BJ. Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines. Leuk Res 2008;32:811-9. [PMID: 17980909 DOI: 10.1016/j.leukres.2007.09.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
357 Wang H, Li Z, Yang B, Yu S, Wu C. IL-27 suppresses the production of IL-22 in human CD4(+) T cells by inducing the expression of SOCS1. Immunol Lett 2013;152:96-103. [PMID: 23727477 DOI: 10.1016/j.imlet.2013.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
358 Arcangeli A, Fontana L, Crociani O, Cherubini A, Hofmann G, Piccini E, Polvani S, D'amico M, Carlà M, Olivotto M. A transient dephosphorylation of JAK1 and JAK2 characterises the early-phase response of murine erythroleukemia cells to the differentiation inducer hexamethylenebisacetamide. Leukemia 2000;14:2112-7. [DOI: 10.1038/sj.leu.2401936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
359 Huang J, Guh J, Chen H, Hung W, Lai Y, Chuang L. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 2001;81:102-13. [DOI: 10.1002/1097-4644(20010401)81:1<102::aid-jcb1027>3.0.co;2-y] [Cited by in Crossref: 136] [Cited by in F6Publishing: 58] [Article Influence: 6.5] [Reference Citation Analysis]
360 Cai YJ, Wang WS, Yang Y, Sun LH, Teitelbaum DH, Yang H. Up-regulation of intestinal epithelial cell derived IL-7 expression by keratinocyte growth factor through STAT1/IRF-1, IRF-2 pathway. PLoS One 2013;8:e58647. [PMID: 23554911 DOI: 10.1371/journal.pone.0058647] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
361 Kiss R, Polgár T, Kirabo A, Sayyah J, Figueroa NC, List AF, Sokol L, Zuckerman KS, Gali M, Bisht KS, Sayeski PP, Keseru GM. Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening. Bioorg Med Chem Lett 2009;19:3598-601. [PMID: 19447617 DOI: 10.1016/j.bmcl.2009.04.138] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
362 Gérard C, Dufour C, Goudenege S, Skuk D, Tremblay JP. AG490 improves the survival of human myoblasts in vitro and in vivo. Cell Transplant 2012;21:2665-76. [PMID: 22963730 DOI: 10.3727/096368912X655028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
363 Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon IM. Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol Cell Biochem 2003;254:247-56. [PMID: 14674704 DOI: 10.1023/a:1027332504861] [Cited by in Crossref: 50] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
364 Lin L, Deangelis S, Foust E, Fuchs J, Li C, Li PK, Schwartz EB, Lesinski GB, Benson D, Lü J. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells. Mol Cancer. 2010;9:217. [PMID: 20712901 DOI: 10.1186/1476-4598-9-217] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 8.1] [Reference Citation Analysis]
365 Terpstra W, Rozemuller H, Breems DA, Rombouts EJ, Prins A, Fitzgerald DJ, Kreitman RJ, Wielenga JJ, Ploemacher RE, Löwenberg B, Hagenbeek A, Martens AC. Diphtheria Toxin Fused to Granulocyte-Macrophage Colony-Stimulating Factor Eliminates Acute Myeloid Leukemia Cells With the Potential to Initiate Leukemia in Immunodeficient Mice, But Spares Normal Hemopoietic Stem Cells. Blood 1997;90:3735-42. [DOI: 10.1182/blood.v90.9.3735] [Cited by in Crossref: 19] [Article Influence: 0.8] [Reference Citation Analysis]
366 Peña G, Cai B, Deitch EA, Ulloa L. JAK2 inhibition prevents innate immune responses and rescues animals from sepsis. J Mol Med (Berl) 2010;88:851-9. [PMID: 20393690 DOI: 10.1007/s00109-010-0628-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
367 May WS. Control of Apoptosis by Cytokines. Apoptosls - Pharmacological Implications and Therapeutic Opportunities. Elsevier; 1997. pp. 219-46. [DOI: 10.1016/s1054-3589(08)61060-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
368 Zhang B, Potyagaylo V, Fenton RG. IL-6-independent expression of Mcl-1 in human multiple myeloma. Oncogene 2003;22:1848-59. [PMID: 12660820 DOI: 10.1038/sj.onc.1206358] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
369 Duarte RF, Frank DA. La vía JAK-STAT de señalización intracelular y su repercusión en oncogénesis, inmunomodulación y desarrollo. Medicina Clínica 2000;114:227-34. [DOI: 10.1016/s0025-7753(00)71252-8] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
370 Kirito K, Watanabe T, Sawada K, Endo H, Ozawa K, Komatsu N. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways. J Biol Chem 2002;277:8329-37. [PMID: 11756417 DOI: 10.1074/jbc.M109824200] [Cited by in Crossref: 67] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
371 Kleinert H, Wallerath T, Fritz G, Ihrig-Biedert I, Rodriguez-Pascual F, Geller DA, Förstermann U. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br J Pharmacol 1998;125:193-201. [PMID: 9776360 DOI: 10.1038/sj.bjp.0702039] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 4.4] [Reference Citation Analysis]
372 Yoshimoto N, Ikeda Y, Tatematsu K, Iijima M, Nakai T, Okajima T, Tanizawa K, Kuroda S. Cytokine-dependent activation of JAK-STAT pathway in Saccharomyces cerevisiae. Biotechnol Bioeng 2016;113:1796-804. [PMID: 26853220 DOI: 10.1002/bit.25948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
373 Zhang Y, Zhang L, Fan X, Yang W, Yu B, Kou J, Li F. Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways. Biomed Pharmacother 2019;113:108780. [PMID: 30889487 DOI: 10.1016/j.biopha.2019.108780] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
374 Chen M, Cheng A, Chen YQ, Hymel A, Hanson EP, Kimmel L, Minami Y, Taniguchi T, Changelian PS, O'Shea JJ. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc Natl Acad Sci U S A 1997;94:6910-5. [PMID: 9192665 DOI: 10.1073/pnas.94.13.6910] [Cited by in Crossref: 94] [Cited by in F6Publishing: 106] [Article Influence: 3.8] [Reference Citation Analysis]
375 Pinz S, Unser S, Brueggemann S, Besl E, Al-Rifai N, Petkes H, Amslinger S, Rascle A. The synthetic α-bromo-2',3,4,4'-tetramethoxychalcone (α-Br-TMC) inhibits the JAK/STAT signaling pathway. PLoS One 2014;9:e90275. [PMID: 24595334 DOI: 10.1371/journal.pone.0090275] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
376 Funakoshi-Tago M, Tago K, Sumi K, Abe M, Aizu-Yokota E, Oshio T, Sonoda Y, Kasahara T. The acute lymphoblastic leukemia-associated JAK2 L611S mutant induces tumorigenesis in nude mice. J Biol Chem 2009;284:12680-90. [PMID: 19289461 DOI: 10.1074/jbc.M808879200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
377 Frank DA. STAT Signaling in the Pathogenesis and Treatment of Cancer. Mol Med 1999;5:432-56. [DOI: 10.1007/bf03403538] [Cited by in Crossref: 77] [Article Influence: 3.3] [Reference Citation Analysis]
378 Sai K, Wang S, Balasubramaniyan V, Conrad C, Lang FF, Aldape K, Szymanski S, Fokt I, Dasgupta A, Madden T, Guan S, Chen Z, Alfred Yung WK, Priebe W, Colman H. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway. J Neurooncol 2012;107:487-501. [PMID: 22249692 DOI: 10.1007/s11060-011-0786-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
379 Kirabo A, Sayeski PP. Jak2 Tyrosine Kinase: A Potential Therapeutic Target for AT1 Receptor Mediated Cardiovascular Disease. Pharmaceuticals 2010;3:3478-93. [DOI: 10.3390/ph3113478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
380 Koay DC, Nguyen T, Sartorelli AC. Distinct region of the granulocyte colony-stimulating factor receptor mediates proliferative signaling through activation of Janus kinase 2 and p44/42 mitogen-activated protein kinase. Cellular Signalling 2002;14:239-47. [DOI: 10.1016/s0898-6568(01)00237-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
381 Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene. 2005;24:4442-4449. [PMID: 15856028 DOI: 10.1038/sj.onc.1208635] [Cited by in Crossref: 124] [Cited by in F6Publishing: 104] [Article Influence: 7.3] [Reference Citation Analysis]
382 López-Talavera JC, Levitzki A, Martínez M, Gazit A, Esteban R, Guardia J. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J Clin Invest 1997;100:664-70. [PMID: 9239414 DOI: 10.1172/JCI119578] [Cited by in Crossref: 38] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
383 Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 2000;87:1195-201. [PMID: 11110778 DOI: 10.1161/01.res.87.12.1195] [Cited by in Crossref: 178] [Cited by in F6Publishing: 51] [Article Influence: 8.5] [Reference Citation Analysis]
384 Constantinescu SN. A new era for small molecule screening: from new targets, such as JAK2 V617F, to complex cellular screens. J Cell Mol Med 2009;13:212-4. [PMID: 19183237 DOI: 10.1111/j.1582-4934.2008.00666.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
385 Pang M, Kothapally J, Mao H, Tolbert E, Ponnusamy M, Chin YE, Zhuang S. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2009;297:F996-F1005. [PMID: 19640900 DOI: 10.1152/ajprenal.00282.2009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 149] [Article Influence: 11.9] [Reference Citation Analysis]
386 Yu X, Li Z, Wan Q, Cheng X, Zhang J, Pathak JL, Li Z. Inhibition of JAK2/STAT3 signaling suppresses bone marrow stromal cells proliferation and osteogenic differentiation, and impairs bone defect healing. Biological Chemistry 2018;399:1313-23. [DOI: 10.1515/hsz-2018-0253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
387 Lanuti P, Bertagnolo V, Pierdomenico L, Bascelli A, Santavenere E, Alinari L, Capitani S, Miscia S, Marchisio M. Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3. Cell Res 2009;19:1079-89. [PMID: 19564891 DOI: 10.1038/cr.2009.80] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
388 Chen E, Gadina M, Chen M, O’shea J. Advances in cytokine signaling: the role of Jaks and STATs. Transplantation Proceedings 1999;31:1482-7. [DOI: 10.1016/s0041-1345(99)00013-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
389 Kumar P, Scholze P, Fronius M, Krasteva-Christ G, Hollenhorst MI. Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors. Br J Pharmacol 2020;177:5595-608. [PMID: 32959891 DOI: 10.1111/bph.15270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
390 Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, Li PK, Li C, Fuchs J, Lin J. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res 2010;70:2445-54. [PMID: 20215512 DOI: 10.1158/0008-5472.CAN-09-2468] [Cited by in Crossref: 151] [Cited by in F6Publishing: 91] [Article Influence: 12.6] [Reference Citation Analysis]
391 Majumder A, Magis AT, Park SO, Figueroa NC, Baskin R, Kirabo A, Allan RW, Zhao ZJ, Bisht KS, Keseru GM, Sayeski PP. A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth. Exp Hematol 2012;40:22-34. [PMID: 22019628 DOI: 10.1016/j.exphem.2011.10.003] [Reference Citation Analysis]
392 Kaneko N, Kita A, Yamanaka K, Mori M. Combination of YM155, a survivin suppressant with a STAT3 inhibitor: A new strategy to treat diffuse large B-cell lymphoma. Leukemia Research 2013;37:1156-61. [DOI: 10.1016/j.leukres.2013.05.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
393 Sharma D, Saxena NK, Vertino PM, Anania FA. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer. 2006;13:629-640. [PMID: 16728588 DOI: 10.1677/erc.1.01169] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 6.4] [Reference Citation Analysis]
394 Biethahn S, Alves F, Wilde S, Hiddemann W, Spiekermann K. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. Exp Hematol 1999;27:885-94. [PMID: 10340405 DOI: 10.1016/s0301-472x(99)00017-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
395 Chang HS, Jeon KW, Kim YH, Chung IY, Park CS. Role of cAMP-dependent pathway in eosinophil apoptosis and survival. Cell Immunol 2000;203:29-38. [PMID: 10915559 DOI: 10.1006/cimm.2000.1668] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
396 Brown GR, Bamford AM, Bowyer J, James DS, Rankine N, Tang E, Torr V, Culbert EJ. Naphthyl ketones: a new class of Janus kinase 3 inhibitors. Bioorganic & Medicinal Chemistry Letters 2000;10:575-9. [DOI: 10.1016/s0960-894x(00)00051-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
397 Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB, Bernstein KE. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J Biol Chem. 1997;272:23382-23388. [PMID: 9287353 DOI: 10.1074/jbc.272.37.23382] [Cited by in Crossref: 167] [Cited by in F6Publishing: 161] [Article Influence: 6.7] [Reference Citation Analysis]
398 Kiss R, Sayeski PP, Keserũ GM. Recent developments on JAK2 inhibitors: a patent review. Expert Opin Ther Pat 2010;20:471-95. [PMID: 20205617 DOI: 10.1517/13543771003639436] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
399 Qian C, Wang J, Yao J, Wang L, Xue M, Liu W, Si J. Involvement of Nuclear JAK2 Signaling in AG490-Induced Apoptosis of Gastric Cancer Cells: Nuclear JAK2 in Gastric Cancer. Anat Rec 2013;296:1865-73. [DOI: 10.1002/ar.22820] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
400 Ren H, Zhao T, Wang X, Gao C, Wang J, Yu M, Hao J. Leptin upregulates telomerase activity and transcription of human telomerase reverse transcriptase in MCF-7 breast cancer cells. Biochemical and Biophysical Research Communications 2010;394:59-63. [DOI: 10.1016/j.bbrc.2010.02.093] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
401 He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 1999;274:25130-5. [PMID: 10455194 DOI: 10.1074/jbc.274.35.25130] [Cited by in Crossref: 345] [Cited by in F6Publishing: 318] [Article Influence: 15.0] [Reference Citation Analysis]
402 Dell’Albani P, Santangelo R, Torrisi L, Nicoletti VG, de Vellis J, Giuffrida Stella AM. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J Neurosci Res. 2001;65:417-424. [PMID: 11536325 DOI: 10.1002/jnr.1169] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 3.7] [Reference Citation Analysis]
403 Xie L, Wu Y, Zhou C, Tan Z, Xu H, Chen G, Chen H, Huang G, Fan H, Gao L, Liu B, Zhou Y. Piceatannol protects against sepsis-induced myocardial dysfunction via direct inhibition of JAK2. Int Immunopharmacol 2021;96:107639. [PMID: 34162128 DOI: 10.1016/j.intimp.2021.107639] [Reference Citation Analysis]
404 Trécul A, Morceau F, Dicato M, Diederich M. Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network. Genes Nutr 2012;7:111-25. [PMID: 22274779 DOI: 10.1007/s12263-012-0281-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
405 Tuyt LM, Bregman K, Lummen C, Dokter WH, Vellenga E. Differential Binding Activity of the Transcription Factor LIL-Stat in Immature and Differentiated Normal and Leukemic Myeloid Cells. Blood 1998;92:1364-73. [DOI: 10.1182/blood.v92.4.1364.416k34_1364_1373] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
406 Menier C, Guillard C, Cassinat B, Carosella ED, Rouas-freiss N. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera. Leukemia 2008;22:578-84. [DOI: 10.1038/sj.leu.2405050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
407 Liu TC, Lin SF, Chang JG, Yang MY, Hung SY, Chang CS. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia. Br J Haematol 2003;123:654-61. [PMID: 14616969 DOI: 10.1046/j.1365-2141.2003.04660.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
408 Wang L, Xue J, Zadorozny EV, Robinson LJ. G-CSF stimulates Jak2-dependent Gab2 phosphorylation leading to Erk1/2 activation and cell proliferation. Cell Signal 2008;20:1890-9. [PMID: 18644434 DOI: 10.1016/j.cellsig.2008.06.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
409 Quarcoo D, Weixler S, Groneberg D, Joachim R, Ahrens B, Wagner AH, Hecker M, Hamelmann E. Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. Journal of Allergy and Clinical Immunology 2004;114:288-95. [DOI: 10.1016/j.jaci.2004.03.055] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]
410 Kim JY, Bae YH, Bae MK, Kim SR, Park HJ, Wee HJ, Bae SK. Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis. Biochim Biophys Acta 2009;1793:1759-67. [PMID: 19751774 DOI: 10.1016/j.bbamcr.2009.09.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
411 Smith MR, Duhe RJ, Liu Y, Farrar WL. Microinjected cDNA encoding JAK2 protein-tyrosine kinase induces DNA synthesis in NIH 3T3 cells. FEBS Lett 1997;408:327-30. [PMID: 9188787 DOI: 10.1016/s0014-5793(97)00456-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
412 Kozawa O, Otsuka T, Uematsu T. Leukemia inhibitory factor enhances bFGF-induced IL-6 synthesis in osteoblasts: involvement of JAK2/STAT3. Cell Signal 2002;14:311-5. [PMID: 11858938 DOI: 10.1016/s0898-6568(01)00248-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
413 Bauvois B, Pramil E, Jondreville L, Quiney C, Nguyen-Khac F, Susin SA. Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway. Biomedicines 2021;9:188. [PMID: 33668421 DOI: 10.3390/biomedicines9020188] [Reference Citation Analysis]
414 Kanai M, Konda Y, Nakajima T, Izumi Y, Kanda N, Nanakin A, Kubohara Y, Chiba T. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Oncogene 2003;22:548-54. [PMID: 12555068 DOI: 10.1038/sj.onc.1206109] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
415 Robek MD, Boyd BS, Wieland SF, Chisari FV. Signal transduction pathways that inhibit hepatitis B virus replication. Proc Natl Acad Sci USA. 2004;101:1743-1747. [PMID: 14757813 DOI: 10.1073/pnas.0308340100] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 2.8] [Reference Citation Analysis]
416 Tonge D, Chan K, Zhu N, Panjwani A, Arno M, Lynham S, Ward M, Snape A, Pizzey J. Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins. J Cell Sci 2008;121:2565-77. [PMID: 18650498 DOI: 10.1242/jcs.024943] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
417 Benekli M, Baer MR, Baumann H, Wetzler M. Signal transducer and activator of transcription proteins in leukemias. Blood. 2003;101:2940-2954. [PMID: 12480704 DOI: 10.1182/blood-2002-04-1204] [Cited by in Crossref: 227] [Cited by in F6Publishing: 222] [Article Influence: 11.4] [Reference Citation Analysis]
418 Nakajima K, Nakamura M, Gao X, Kozakai T. Possible Involvement of Prolactin in the Synthesis of Lactoferrin in Bovine Mammary Epithelial Cells. Bioscience, Biotechnology, and Biochemistry 2014;72:1103-6. [DOI: 10.1271/bbb.70713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
419 Fioravanti S, Pellacani L, Tardella PA, Morreale A, Del Signore G. Parallel Solution-Phase Synthesis of Acrylonitrile Scaffolds Carrying l -α-Amino Acidic or d -Glycosyl Residues. J Comb Chem 2006;8:808-11. [DOI: 10.1021/cc060029k] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
420 Montresor A, Toffali L, Mirenda M, Rigo A, Vinante F, Laudanna C. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia. Oncotarget 2015;6:34245-57. [PMID: 26413812 DOI: 10.18632/oncotarget.5196] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
421 Zhang Z, Xing J, Ma L, Gong R, Chin YE, Zhuang S. Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3. J Biol Chem 2009;284:3345-53. [PMID: 19049964 DOI: 10.1074/jbc.M808396200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
422 Okugawa S, Ota Y, Kitazawa T, Nakayama K, Yanagimoto S, Tsukada K, Kawada M, Kimura S. Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages. Am J Physiol Cell Physiol 2003;285:C399-408. [PMID: 12686512 DOI: 10.1152/ajpcell.00026.2003] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 5.2] [Reference Citation Analysis]
423 Dijkers PF, van Dijk TB, de Groot RP, Raaijmakers JA, Lammers JJ, Koenderman L, Coffer PJ. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor. Oncogene 1999;18:3334-42. [DOI: 10.1038/sj.onc.1202678] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
424 Ding BB, Yu JJ, Yu RY, Mendez LM, Shaknovich R, Zhang Y, Cattoretti G, Ye BH. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 2008;111:1515-23. [PMID: 17951530 DOI: 10.1182/blood-2007-04-087734] [Cited by in Crossref: 212] [Cited by in F6Publishing: 212] [Article Influence: 14.1] [Reference Citation Analysis]
425 Marrero MB, Papke RL, Bhatti BS, Shaw S, Bencherif M. The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase. J Pharmacol Exp Ther 2004;309:16-27. [PMID: 14722323 DOI: 10.1124/jpet.103.061655] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
426 Son YO, Park S, Kwak JS, Won Y, Choi WS, Rhee J, Chun CH, Ryu JH, Kim DK, Choi HS, Chun JS. Estrogen-related receptor γ causes osteoarthritis by upregulating extracellular matrix-degrading enzymes. Nat Commun 2017;8:2133. [PMID: 29247173 DOI: 10.1038/s41467-017-01868-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
427 Welsh M, Welsh C, Ekman M, Dixelius J, Hägerkvist R, Annerén C, Akerblom B, Mahboobi S, Chandrasekharan S, Liu ET. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity. Biochem J 2004;382:261-8. [PMID: 15186217 DOI: 10.1042/BJ20040285] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
428 Krügel K, Wurm A, Linnertz R, Pannicke T, Wiedemann P, Reichenbach A, Bringmann A. Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase- and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor. Neuroscience 2010;165:1147-58. [DOI: 10.1016/j.neuroscience.2009.11.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
429 Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67:2497-2507. [PMID: 17363567 DOI: 10.1158/0008-5472.can-06-3075] [Cited by in Crossref: 324] [Cited by in F6Publishing: 175] [Article Influence: 21.6] [Reference Citation Analysis]
430 Akasaka Y, Tsunoda M, Ide T, Murakami K. Chronic leptin treatment stimulates lipid oxidation in immortalized and primary mouse skeletal muscle cells. Biochim Biophys Acta 2009;1791:103-9. [PMID: 19103304 DOI: 10.1016/j.bbalip.2008.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
431 Sayyah J, Sayeski PP. Jak2 inhibitors: rationale and role as therapeutic agents in hematologic malignancies. Curr Oncol Rep 2009;11:117-24. [PMID: 19216843 DOI: 10.1007/s11912-009-0018-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
432 Chen Q, Lv J, Yang W, Xu B, Wang Z, Yu Z, Wu J, Yang Y, Han Y. Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis. Theranostics 2019;9:6424-42. [PMID: 31588227 DOI: 10.7150/thno.35528] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
433 Chen CW, Chao Y, Chang YH, Hsu MJ, Lin WW. Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid. Br J Pharmacol 2002;137:1011-20. [PMID: 12429573 DOI: 10.1038/sj.bjp.0704955] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
434 Choudhary C, Brandts C, Schwable J, Tickenbrock L, Sargin B, Ueker A, Böhmer FD, Berdel WE, Müller-Tidow C, Serve H. Activation mechanisms of STAT5 by oncogenic Flt3-ITD. Blood 2007;110:370-4. [PMID: 17356133 DOI: 10.1182/blood-2006-05-024018] [Cited by in Crossref: 141] [Cited by in F6Publishing: 134] [Article Influence: 9.4] [Reference Citation Analysis]
435 Shao S, Yu R, Yu Y, Li Y. Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations. J Mol Model 2014;20:2399. [PMID: 25098340 DOI: 10.1007/s00894-014-2399-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
436 Gorina R, Petegnief V, Chamorro A, Planas AM. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway. J Neurochem 2005;92:505-18. [DOI: 10.1111/j.1471-4159.2004.02878.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
437 Horiguchi A, Asano T, Kuroda K, Sato A, Asakuma J, Ito K, Hayakawa M, Sumitomo M, Asano T. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma. Br J Cancer 2010;102:1592-9. [PMID: 20461084 DOI: 10.1038/sj.bjc.6605691] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
438 Gu Y, Zou Y, Aikawa R, Hayashi D, Kudoh S, Yamauchi T, Uozumi H, Zhu W, Kadowaki T, Yazaki Y, Komuro I. Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes. Mol Cell Biochem 2001;223:35-46. [PMID: 11681720 DOI: 10.1023/a:1017941625858] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
439 Sayeski PP, Ali MS, Safavi A, Lyles M, Kim S, Frank SJ, Bernstein KE. A Catalytically Active Jak2 Is Required for the Angiotensin II-dependent Activation of Fyn. Journal of Biological Chemistry 1999;274:33131-42. [DOI: 10.1074/jbc.274.46.33131] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
440 Borie DC, O'shea JJ, Changelian PS. JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants. Trends in Molecular Medicine 2004;10:532-41. [DOI: 10.1016/j.molmed.2004.09.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
441 Ellis AG, Doherty MM, Walker F, Weinstock J, Nerrie M, Vitali A, Murphy R, Johns TG, Scott AM, Levitzki A, McLachlan G, Webster LK, Burgess AW, Nice EC. Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochem Pharmacol 2006;71:1422-34. [PMID: 16522318 DOI: 10.1016/j.bcp.2006.01.020] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
442 Andraos R, Qian Z, Bonenfant D, Rubert J, Vangrevelinghe E, Scheufler C, Marque F, Régnier CH, De Pover A, Ryckelynck H, Bhagwat N, Koppikar P, Goel A, Wyder L, Tavares G, Baffert F, Pissot-Soldermann C, Manley PW, Gaul C, Voshol H, Levine RL, Sellers WR, Hofmann F, Radimerski T. Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent. Cancer Discov 2012;2:512-23. [PMID: 22684457 DOI: 10.1158/2159-8290.CD-11-0324] [Cited by in Crossref: 88] [Cited by in F6Publishing: 50] [Article Influence: 8.8] [Reference Citation Analysis]
443 Hanisch U, Prinz M, Angstwurm K, Häusler KG, Kann O, Kettenmann H, Weber JR. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur J Immunol 2001;31:2104-15. [DOI: 10.1002/1521-4141(200107)31:7<2104::aid-immu2104>3.0.co;2-3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
444 Qin S, Ding J, Kurosaki T, Yamamura H. A deficiency in Syk enhances ceramide-induced apoptosis in DT40 lymphoma B cells. FEBS Lett 1998;427:139-43. [PMID: 9613615 DOI: 10.1016/s0014-5793(98)00383-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
445 Peron M, Dinarello A, Meneghetti G, Martorano L, Facchinello N, Vettori A, Licciardello G, Tiso N, Argenton F. The stem-like Stat3-responsive cells of zebrafish intestine are Wnt/β-catenin dependent. Development 2020;147:dev188987. [PMID: 32467235 DOI: 10.1242/dev.188987] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
446 Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Mol Endocrinol 2001;15:1941-52. [PMID: 11682625 DOI: 10.1210/mend.15.11.0722] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
447 Chiang SY, Kim SM, Kim C, Um JY, Park KR, Kim SW, Lee SG, Jang HJ, Nam D, Ahn KS, Kim SH, Choi SH, Shim BS, Na YC, Jeong EK, Cho SK, Ahn KS. Antiproliferative effects of Dangyuja (Citrus grandis Osbeck) leaves through suppression of constitutive signal transducer and activator of transcription 3 activation in human prostate carcinoma DU145 cells. J Med Food 2012;15:152-60. [PMID: 22273151 DOI: 10.1089/jmf.2011.1671] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
448 Gringeri E, Carraro A, Tibaldi E, D’Amico FE, Mancon M, Toninello A, Pagano MA, Vio C, Cillo U, Brunati AM. Lyn-mediated mitochondrial tyrosine phosphorylation is required to preserve mitochondrial integrity in early liver regeneration. Biochem J. 2010;425:401-412. [PMID: 19832701 DOI: 10.1042/bj20090902] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
449 Hinterding K, Knebel A, Herrlich P, Waldmann H. Synthesis and biological evaluation of aeroplysinin analogues: a new class of receptor tyrosine kinase inhibitors. Bioorg Med Chem 1998;6:1153-62. [PMID: 9784857 DOI: 10.1016/s0968-0896(98)00070-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
450 Wang K, Wang C, Xiao F, Wang H, Wu Z. JAK2/STAT2/STAT3 are required for myogenic differentiation. J Biol Chem 2008;283:34029-36. [PMID: 18835816 DOI: 10.1074/jbc.M803012200] [Cited by in Crossref: 92] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
451 Jobst B, Weigl J, Michl C, Vivarelli F, Pinz S, Amslinger S, Rascle A. Inhibition of interleukin-3- and interferon- α-induced JAK/STAT signaling by the synthetic α-X-2′,3,4,4′-tetramethoxychalcones α-Br-TMC and α-CF3-TMC. Biological Chemistry 2016;397:1187-204. [DOI: 10.1515/hsz-2016-0148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
452 Opdam FJ, Kamp M, de Bruijn R, Roos E. Jak kinase activity is required for lymphoma invasion and metastasis. Oncogene 2004;23:6647-53. [PMID: 15235585 DOI: 10.1038/sj.onc.1207887] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
453 Xu L, Enyeart JJ. Properties of ATP-dependent K(+) channels in adrenocortical cells. Am J Physiol Cell Physiol 2001;280:C199-215. [PMID: 11121392 DOI: 10.1152/ajpcell.2001.280.1.C199] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
454 Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene. 2002;21:7001-7010. [PMID: 12370822 DOI: 10.1038/sj.onc.1205859] [Cited by in Crossref: 303] [Cited by in F6Publishing: 291] [Article Influence: 15.2] [Reference Citation Analysis]
455 de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6:844-851. [PMID: 16025117 DOI: 10.1038/ni1229] [Cited by in Crossref: 674] [Cited by in F6Publishing: 653] [Article Influence: 39.6] [Reference Citation Analysis]
456 Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher MA, Neuberg DS, Levine RL, Moriggl R, Müller M, Gray NS, Jamieson CH, Weng AP, Staudt LM, Druker BJ, Look AT. TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discov 2013;3:564-77. [PMID: 23471820 DOI: 10.1158/2159-8290.CD-12-0504] [Cited by in Crossref: 91] [Cited by in F6Publishing: 62] [Article Influence: 10.1] [Reference Citation Analysis]
457 De Breuck S, Baeyens L, Bouwens L. Expression and function of leukaemia inhibitory factor and its receptor in normal and regenerating rat pancreas. Diabetologia 2006;49:108-16. [DOI: 10.1007/s00125-005-0079-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
458 Ward AC, Hermans MH, Smith L, van Aesch YM, Schelen AM, Antonissen C, Touw IP. Tyrosine-Dependent and -Independent Mechanisms of STAT3 Activation by the Human Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Are Differentially Utilized Depending on G-CSF Concentration. Blood 1999;93:113-24. [DOI: 10.1182/blood.v93.1.113] [Cited by in Crossref: 78] [Article Influence: 3.4] [Reference Citation Analysis]
459 Schwaller J, Parganas E, Wang D, Cain D, Aster JC, Williams IR, Lee C, Gerthner R, Kitamura T, Frantsve J, Anastasiadou E, Loh ML, Levy DE, Ihle JN, Gilliland D. Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2. Molecular Cell 2000;6:693-704. [DOI: 10.1016/s1097-2765(00)00067-8] [Cited by in Crossref: 232] [Cited by in F6Publishing: 95] [Article Influence: 10.5] [Reference Citation Analysis]
460 Han C, Sun B, Zhao X, Zhang Y, Gu Q, Liu F, Zhao N, Wu L. Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer. Technol Cancer Res Treat. 2017;16:1209-1219. [PMID: 29333928 DOI: 10.1177/1533034617742312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
461 Lyons DJ, Hellysaz A, Broberger C. Prolactin regulates tuberoinfundibular dopamine neuron discharge pattern: novel feedback control mechanisms in the lactotrophic axis. J Neurosci 2012;32:8074-83. [PMID: 22674282 DOI: 10.1523/JNEUROSCI.0129-12.2012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
462 Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene. 2002;21:8404-8413. [PMID: 12466961 DOI: 10.1038/sj.onc.1206047] [Cited by in Crossref: 259] [Cited by in F6Publishing: 256] [Article Influence: 13.6] [Reference Citation Analysis]
463 Damm J, Harden LM, Gerstberger R, Roth J, Rummel C. The putative JAK-STAT inhibitor AG490 exacerbates LPS-fever, reduces sickness behavior, and alters the expression of pro- and anti-inflammatory genes in the rat brain. Neuropharmacology 2013;71:98-111. [DOI: 10.1016/j.neuropharm.2013.03.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
464 Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Matsuda T, Tanaka Y, Ohshiro K, Mori N. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. Retrovirology. 2006;3:22. [PMID: 16603085 DOI: 10.1186/1742-4690-3-22] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
465 Hoshino A, Hirst JA, Fujii H. Regulation of Cell Proliferation by Interleukin-3-induced Nuclear Translocation of Pyruvate Kinase. Journal of Biological Chemistry 2007;282:17706-11. [DOI: 10.1074/jbc.m700094200] [Cited by in Crossref: 70] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
466 Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OMZ, Farrar W, Wang JM. Formylpeptide Receptor FPR and the Rapid Growth of Malignant Human Gliomas. JNCI: Journal of the National Cancer Institute 2005;97:823-35. [DOI: 10.1093/jnci/dji142] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 5.2] [Reference Citation Analysis]
467 Keeshan K, Cotter TG, McKenna SL. High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion. Leukemia 2002;16:1725-34. [PMID: 12200687 DOI: 10.1038/sj.leu.2402576] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
468 Noor SM, Bell R, Ward AC. Shooting the messenger: Targeting signal transduction pathways in leukemia and related disorders. Critical Reviews in Oncology/Hematology 2011;78:33-44. [DOI: 10.1016/j.critrevonc.2010.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
469 Le MN, Kohanski RA, Wang L, Sadowski HB. Dual Mechanism of Signal Transducer and Activator of Transcription 5 Activation by the Insulin Receptor. Molecular Endocrinology 2002;16:2764-79. [DOI: 10.1210/me.2002-0017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
470 Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol. 2003;197:157-168. [PMID: 14502555 DOI: 10.1002/jcp.10364] [Cited by in Crossref: 415] [Cited by in F6Publishing: 402] [Article Influence: 21.8] [Reference Citation Analysis]
471 Chung EY, Kim BH, Lee IJ, Roh E, Oh SJ, Kwak JA, Lee YR, Ahn B, Nam SY, Han SB, Kim Y. The benzoxathiolone LYR-71 down-regulates interferon-gamma-inducible pro-inflammatory genes by uncoupling tyrosine phosphorylation of STAT-1 in macrophages. Br J Pharmacol 2009;158:1971-81. [PMID: 19922538 DOI: 10.1111/j.1476-5381.2009.00496.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
472 Li JJ, Tu J, Cheng P, Zhai HL, Zhang XY. Insights into DFG-in and DFG-out JAK2 binding modes for a rational strategy of type II inhibitors combined computational study. RSC Adv 2016;6:45540-52. [DOI: 10.1039/c6ra06266k] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
473 Ali M, Sayeski P, Safavi A, Lyles M, Bernstein K. Janus Kinase 2 (Jak2) Must Be Catalytically Active to Associate with the AT1Receptor in Response to Angiotensin II. Biochemical and Biophysical Research Communications 1998;249:672-7. [DOI: 10.1006/bbrc.1998.9054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
474 Cavicchi M, Whittle BJ. Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation. Br J Pharmacol. 1999;128:705-715. [PMID: 10516652 DOI: 10.1038/sj.bjp.0702827] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
475 Izumi-Nagai K, Nagai N, Ozawa Y, Mihara M, Ohsugi Y, Kurihara T, Koto T, Satofuka S, Inoue M, Tsubota K, Okano H, Oike Y, Ishida S. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol 2007;170:2149-58. [PMID: 17525280 DOI: 10.2353/ajpath.2007.061018] [Cited by in Crossref: 80] [Cited by in F6Publishing: 92] [Article Influence: 5.3] [Reference Citation Analysis]
476 Yu JH, Kim KH, Kim H. Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells. Biochem Pharmacol. 2006;72:1555-1562. [PMID: 16934228 DOI: 10.1016/j.bcp.2006.07.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
477 Rich BE. IL-20: a new target for the treatment of inflammatory skin disease. Expert Opinion on Therapeutic Targets 2005;7:165-74. [DOI: 10.1517/14728222.7.2.165] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
478 Durrbach A, Francois H, Beaudreuil S, Jacquet A, Charpentier B. Advances in immunosuppression for renal transplantation. Nat Rev Nephrol 2010;6:160-7. [DOI: 10.1038/nrneph.2009.233] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
479 Levitzki A, Klein S. Signal transduction therapy of cancer. Molecular Aspects of Medicine 2010;31:287-329. [DOI: 10.1016/j.mam.2010.04.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
480 Shen XL, Wei W, Xu HL, Zhang MX, Qin XQ, Shi WZ, Jiang ZP, Chen YJ, Chen FP. JAK2V617F/STAT5 signaling pathway promotes cell proliferation through activation of Pituitary Tumor Transforming Gene 1 expression. Biochem Biophys Res Commun 2010;398:707-12. [PMID: 20621061 DOI: 10.1016/j.bbrc.2010.07.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
481 Bridges A. Current progress towards the development of tyrosine kinase inhibitors as anticancer agents. Emerging Drugs 2005;3:279-92. [DOI: 10.1517/14728214.3.1.279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
482 Dalal I, Arpaia E, Dadi H, Kulkarni S, Squire J, Roifman CM. Cloning and Characterization of the Human Homolog of Mouse Jak2. Blood 1998;91:844-51. [DOI: 10.1182/blood.v91.3.844] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
483 Beà A, Valero JG, Irazoki A, Lana C, López-Lluch G, Portero-Otín M, Pérez-Galán P, Inserte J, Ruiz-Meana M, Zorzano A, Llovera M, Sanchis D. Cardiac fibroblasts display endurance to ischemia, high ROS control and elevated respiration regulated by the JAK2/STAT pathway. FEBS J 2021. [PMID: 34796659 DOI: 10.1111/febs.16283] [Reference Citation Analysis]
484 Jo C, Kim H, Jo I, Choi I, Jung S, Kim J, Kim SS, Jo SA. Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2005;1743:187-97. [DOI: 10.1016/j.bbamcr.2004.11.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
485 Frank DA. StAT signaling in cancer: insights into pathogenesis and treatment strategies. Cancer Treat Res. 2003;115:267-291. [PMID: 12613201 DOI: 10.1007/0-306-48158-8_11] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
486 Freitas MC, Uchida Y, Zhao D, Ke B, Busuttil RW, Kupiec-Weglinski JW. Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl 2010;16:600-10. [PMID: 20440769 DOI: 10.1002/lt.22036] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
487 O'Shea JJ, Notarangelo LD, Johnston JA, Candotti F. Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency. J Clin Immunol 1997;17:431-47. [PMID: 9418183 DOI: 10.1023/a:1027388508570] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
488 David M, Ford D, Bertoglio J, Maizel AL, Pierre J. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 2001;20:6660-8. [PMID: 11709700 DOI: 10.1038/sj.onc.1204629] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 3.2] [Reference Citation Analysis]
489 Guo Y, Mascareno E, Siddiqui MAQ. Distinct Components of Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway Mediate the Regulation of Systemic and Tissue Localized Renin-Angiotensin System. Molecular Endocrinology 2004;18:1033-41. [DOI: 10.1210/me.2003-0231] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
490 Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002;109:1139-42. [PMID: 11994401 DOI: 10.1172/JCI15617] [Cited by in Crossref: 21] [Cited by in F6Publishing: 298] [Article Influence: 1.1] [Reference Citation Analysis]
491 Gharavi NM, Alva JA, Mouillesseaux KP, Lai C, Yeh M, Yeung W, Johnson J, Szeto WL, Hong L, Fishbein M, Wei L, Pfeffer LM, Berliner JA. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem. 2007;282:31460-31468. [PMID: 17726017 DOI: 10.1074/jbc.m704267200] [Cited by in Crossref: 101] [Cited by in F6Publishing: 56] [Article Influence: 6.7] [Reference Citation Analysis]
492 Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A. 1996;93:9148-9153. [PMID: 8799169 DOI: 10.1073/pnas.93.17.9148] [Cited by in Crossref: 166] [Cited by in F6Publishing: 164] [Article Influence: 6.4] [Reference Citation Analysis]
493 Granato M, Chiozzi B, Filardi MR, Lotti LV, Di Renzo L, Faggioni A, Cirone M. Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells. Cancer Lett 2015;366:191-7. [PMID: 26184999 DOI: 10.1016/j.canlet.2015.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
494 Levitzki A. Tyrosine kinases as targets for cancer therapy. European Journal of Cancer 2002;38:S11-8. [DOI: 10.1016/s0959-8049(02)80598-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
495 Sasaguri T, Teruya H, Ishida A, Abumiya T, Ogata J. Linkage between alpha(1) adrenergic receptor and the Jak/STAT signaling pathway in vascular smooth muscle cells. Biochem Biophys Res Commun 2000;268:25-30. [PMID: 10652206 DOI: 10.1006/bbrc.1999.2066] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
496 Vichalkovski A, Baltensperger K, Thomann D, Porzig H. Two different pathways link G-protein-coupled receptors with tyrosine kinases for the modulation of growth and survival in human hematopoietic progenitor cells. Cellular Signalling 2005;17:447-59. [DOI: 10.1016/j.cellsig.2004.09.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
497 Randi ML, Brunati AM, Scapin M, Frasson M, Deana R, Magrin E, Fabris F, Donella-deana A. Src tyrosine kinase preactivation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera. Blood 2010;115:667-76. [DOI: 10.1182/blood-2008-12-196535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
498 Marasco WA. Antibodies for targeted gene therapy: extracellular gene targeting and intracellular expression. Adv Drug Deliv Rev. 1998;31:153-170. [PMID: 10837623 DOI: 10.1016/s0169-409x(97)00099-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
499 Lu WJ, Lin KC, Huang SY, Thomas PA, Wu YH, Wu HC, Lin KH, Sheu JR. Role of a Janus kinase 2-dependent signaling pathway in platelet activation. Thromb Res 2014;133:1088-96. [PMID: 24731555 DOI: 10.1016/j.thromres.2014.03.042] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
500 Kirabo A, Oh SP, Kasahara H, Wagner KU, Sayeski PP. Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice. J Mol Cell Cardiol 2011;50:1026-34. [PMID: 21420414 DOI: 10.1016/j.yjmcc.2011.03.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
501 Vila‐coro AJ, Rodríguez‐frade JM, De Ana AM, Moreno‐ortíz MC, Martínez‐a. C, Mellado M. The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB j 1999;13:1699-710. [DOI: 10.1096/fasebj.13.13.1699] [Cited by in Crossref: 367] [Cited by in F6Publishing: 220] [Article Influence: 16.0] [Reference Citation Analysis]
502 Harris KW, Hu X, Schultz S, Arcasoy MO, Forget BG, Clare N. The Distal Cytoplasmic Domain of the Erythropoietin Receptor Induces Granulocytic Differentiation in 32D Cells. Blood 1998;92:1219-24. [DOI: 10.1182/blood.v92.4.1219] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
503 Rashid S, Bibi N, Parveen Z, Shafique S. Inhibition of Janus kinases by tyrosine phosphorylation inhibitor, Tyrphostin AG-490. J Biomol Struct Dyn 2015;33:2368-79. [PMID: 26017266 DOI: 10.1080/07391102.2015.1050696] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
504 Wong WS, Leong KP. Tyrosine kinase inhibitors: a new approach for asthma. Biochim Biophys Acta 2004;1697:53-69. [PMID: 15023350 DOI: 10.1016/j.bbapap.2003.11.013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
505 Levine RL, Wernig G. Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders. Hematology 2006;2006:233-9. [DOI: 10.1182/asheducation-2006.1.233] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
506 Gopalan A, Yu W, Sanders BG, Kline K. Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol. Cancer Letters 2013;328:285-96. [DOI: 10.1016/j.canlet.2012.10.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
507 Martinez-Lostao L, Briones J, Forné I, Martinez-Gallo M, Ferrer B, Sierra J, Rodriguez-Sanchez JL, Juarez C. Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2005;46:435-42. [PMID: 15621835 DOI: 10.1080/10428190400018398] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
508 Romagnoli R, Baraldi PG, Salvador MK, Chayah M, Camacho ME, Prencipe F, Hamel E, Consolaro F, Basso G, Viola G. Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agents. Eur J Med Chem 2014;81:394-407. [PMID: 24858544 DOI: 10.1016/j.ejmech.2014.05.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
509 Kamal A, Bajee S, Lakshma Nayak V, Venkata Subba Rao A, Nagaraju B, Ratna Reddy C, Jeevak Sopanrao K, Alarifi A. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents. Bioorg Med Chem Lett 2016;26:2957-64. [PMID: 27161282 DOI: 10.1016/j.bmcl.2016.03.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
510 Pollack BP, Kotenko SV, He W, Izotova LS, Barnoski BL, Pestka S. The Human Homologue of the Yeast Proteins Skb1 and Hsl7p Interacts with Jak Kinases and Contains Protein Methyltransferase Activity. Journal of Biological Chemistry 1999;274:31531-42. [DOI: 10.1074/jbc.274.44.31531] [Cited by in Crossref: 195] [Cited by in F6Publishing: 204] [Article Influence: 8.5] [Reference Citation Analysis]
511 Chaudhary V, Yuen KS, Chan JF, Chan CP, Wang PH, Cai JP, Zhang S, Liang M, Kok KH, Chan CP, Yuen KY, Jin DY. Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein. J Virol 2017;91:e00163-17. [PMID: 28468880 DOI: 10.1128/JVI.00163-17] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 11.6] [Reference Citation Analysis]
512 Davoodi-Semiromi A, Wasserfall CH, Xia CQ, Cooper-DeHoff RM, Wabitsch M, Clare-Salzler M, Atkinson M. The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice. PLoS One 2012;7:e36079. [PMID: 22615750 DOI: 10.1371/journal.pone.0036079] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
513 Pesu M, Candotti F, Husa M, Hofmann SR, Notarangelo LD, O'shea JJ. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Immunol Rev 2005;203:127-42. [DOI: 10.1111/j.0105-2896.2005.00220.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
514 Huyer G, Kelly J, Moffat J, Zamboni R, Jia Z, Gresser MJ, Ramachandran C. Affinity Selection from Peptide Libraries to Determine Substrate Specificity of Protein Tyrosine Phosphatases. Analytical Biochemistry 1998;258:19-30. [DOI: 10.1006/abio.1997.2541] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 2.4] [Reference Citation Analysis]
515 Masamune A, Satoh M, Kikuta K, Suzuki N, Shimosegawa T. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells. World J Gastroenterol 2005; 11(22): 3385-3391 [PMID: 15948243 DOI: 10.3748/wjg.v11.i22.3385] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
516 Ruchatz H, Coluccia AML, Stano P, Marchesi E, Gambacorti-passerini C. Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells. Experimental Hematology 2003;31:309-15. [DOI: 10.1016/s0301-472x(03)00007-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
517 Yu T, Wang Z, Jie W, Fu X, Li B, Xu H, Liu Y, Li M, Kim E, Yang Y, Cho JY. The kinase inhibitor BX795 suppresses the inflammatory response via multiple kinases. Biochemical Pharmacology 2020;174:113797. [DOI: 10.1016/j.bcp.2020.113797] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
518 Kunioku H, Inoue K, Tomida M. Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways. Neurosci Lett. 2001;309:13-16. [PMID: 11489535 DOI: 10.1016/S0304-3940(01)02012-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
519 Zong CS, Chan J, Levy DE, Horvath C, Sadowski HB, Wang LH. Mechanism of STAT3 activation by insulin-like growth factor I receptor. J Biol Chem 2000;275:15099-105. [PMID: 10747872 DOI: 10.1074/jbc.M000089200] [Cited by in Crossref: 159] [Cited by in F6Publishing: 70] [Article Influence: 7.2] [Reference Citation Analysis]
520 S??emann MD, B??hmig GA, ??sterreicher CH, Staffler G, Diakos C, Krieger P, H??rl WH, Stockinger H, Zlabinger GJ. SUPPRESSION OF PRIMARY T-CELL RESPONSES AND INDUCTION OF ALLOANTIGEN-SPECIFIC HYPORESPONSIVENESS IN VITRO BY THE JANUS KINASE INHIBITOR TYRPHOSTIN AG4901: . Transplantation 2000;70:1215-25. [DOI: 10.1097/00007890-200010270-00016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
521 Zheng R, Friedman AD, Small D. Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations. Blood 2002;100:4154-61. [DOI: 10.1182/blood-2002-03-0936] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 3.3] [Reference Citation Analysis]
522 Kubota Y, Tanaka T, Ohnishi H, Kitanaka A, Okutani Y, Taminato T, Ishida T, Kamano H. Constitutively activated phosphatidylinositol 3-kinase primes platelets from patients with chronic myelogenous leukemia for thrombopoietin-induced aggregation. Leukemia 2004;18:1127-37. [PMID: 15085152 DOI: 10.1038/sj.leu.2403370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
523 Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE. Janus kinase 2 is involved in stromal cell-derived factor-1 alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood. 2001;97:3342-3348. [PMID: 11369622 DOI: 10.1182/blood.V97.11.3342] [Cited by in Crossref: 120] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
524 Wang LH, Kirken RA, Yang XY, Erwin RA, Dasilva L, Yu C, Farrar WL. Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells. Blood 2000;95:3816-22. [DOI: 10.1182/blood.v95.12.3816] [Cited by in Crossref: 14] [Article Influence: 0.6] [Reference Citation Analysis]
525 Behbod F, Erwin-Cohen RA, Wang ME, Trawick BW, Qu X, Verani R, Kahan BD, Stepkowski SM, Kirken RA. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts. J Immunol 2001;166:3724-32. [PMID: 11238613 DOI: 10.4049/jimmunol.166.6.3724] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
526 Sun M, Liu C, Nadiminty N, Lou W, Zhu Y, Yang J, Evans CP, Zhou Q, Gao AC. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate. 2012;72:82-89. [PMID: 21538419 DOI: 10.1002/pros.21409] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
527 Ontsouka CE, Huang X, Aliyev E, Albrecht C. In vitro characterization and endocrine regulation of cholesterol and phospholipid transport in the mammary gland. Molecular and Cellular Endocrinology 2017;439:35-45. [DOI: 10.1016/j.mce.2016.10.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
528 Horiguchi A, Oya M, Marumo K, Murai M. STAT3, but not ERKs, mediates the IL-6–induced proliferation of renal cancer cells, ACHN and 769P. Kidney International 2002;61:926-38. [DOI: 10.1046/j.1523-1755.2002.00206.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
529 Gao L, Wen L, Yu H, Zhang L, Meng Y, Shao Y, Xu D, Zhao X. Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo. Acta Pharmacologica Sinica 2006;27:347-52. [DOI: 10.1111/j.1745-7254.2006.00277.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
530 Stafford S, Lowell C, Sur S, Alam R. Lyn Tyrosine Kinase Is Important for IL-5-Stimulated Eosinophil Differentiation. J Immunol 2002;168:1978-83. [DOI: 10.4049/jimmunol.168.4.1978] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
531 Brady MT, Miller A, Sait SN, Ford LA, Minderman H, Wang ES, Lee KP, Baumann H, Wetzler M. Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function. Leuk Res 2013;37:822-8. [PMID: 23628554 DOI: 10.1016/j.leukres.2013.04.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
532 Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L, Pinna LA, Zambello R, Semenzato G, Donella-Deana A. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 2005;115:369-78. [PMID: 15650771 DOI: 10.1172/JCI22094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 80] [Article Influence: 0.1] [Reference Citation Analysis]
533 Ito T, Ikeda K, Tomita K, Yokoyama S. Interleukin-6 upregulates the expression of PMP22 in cultured rat Schwann cells via a JAK2-dependent pathway. Neuroscience Letters 2010;472:104-8. [DOI: 10.1016/j.neulet.2010.01.061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
534 Milbradt J, Webel R, Auerochs S, Sticht H, Marschall M. Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus. J Biol Chem 2010;285:13979-89. [PMID: 20202933 DOI: 10.1074/jbc.M109.063628] [Cited by in Crossref: 69] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
535 La Starza R, Vitale A, Serra A, Saglio G, Fioritoni G, Falzetti D, Martelli MF, Foà R, Mecucci C. Philadelphia-positive acute lymphoblastic leukemia with multiple subclones including duplication of the Philadelphia chromosome and Abelson oncogene. Cancer Genet Cytogenet 2002;132:46-50. [PMID: 11801308 DOI: 10.1016/s0165-4608(01)00507-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
536 Yoshida C, Melo JV. Biology of Chronic Myeloid Leukemia and Possible Therapeutic Approaches to Imatinib-Resistant Disease. International Journal of Hematology 2004;79:420-33. [DOI: 10.1532/ijh97.04032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
537 Liang R, Chen X, Chen L, Wan F, Chen K, Sun Y, Zhu X. STAT3 signaling in ovarian cancer: a potential therapeutic target. J Cancer 2020;11:837-48. [PMID: 31949487 DOI: 10.7150/jca.35011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
538 Giordanetto F, Kroemer RT. Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. Protein Eng 2002;15:727-37. [PMID: 12456871 DOI: 10.1093/protein/15.9.727] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.3] [Reference Citation Analysis]
539 Zhou Y, Sun Y, Hou W, Ma L, Tao Y, Li D, Xu C, Bao J, Fan W. The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro. Int J Mol Med 2020;46:191-200. [PMID: 32377718 DOI: 10.3892/ijmm.2020.4592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
540 Larrea E, Aldabe R, Molano E, Fernandez-Rodriguez CM, Ametzazurra A, Civeira MP, Prieto J. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies. Gut. 2006;55:1188-1196. [PMID: 16120756 DOI: 10.1136/gut.2005.070060] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
541 Jiang X, Kanda T, Wu S, Nakamoto S, Saito K, Shirasawa H, Kiyohara T, Ishii K, Wakita T, Okamoto H, Yokosuka O. Suppression of La antigen exerts potential antiviral effects against hepatitis A virus. PLoS One. 2014;9:e101993. [PMID: 24999657 DOI: 10.1371/journal.pone.0101993] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
542 Cheng F, Wang H, Cuenca A, Huang M, Ghansah T, Brayer J, Kerr WG, Takeda K, Akira S, Schoenberger SP, Yu H, Jove R, Sotomayor EM. A Critical Role for Stat3 Signaling in Immune Tolerance. Immunity 2003;19:425-36. [DOI: 10.1016/s1074-7613(03)00232-2] [Cited by in Crossref: 266] [Cited by in F6Publishing: 130] [Article Influence: 14.0] [Reference Citation Analysis]
543 Doi M, Shichiri M, Katsuyama K, Ishimaru S, Hirata Y. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-κB activation in vascular smooth muscle cells. Atherosclerosis 2002;160:123-32. [DOI: 10.1016/s0021-9150(01)00578-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
544 Kaulsay KK, Mertani HC, Lee K, Lobie PE. Autocrine Human Growth Hormone Enhancement of Human Mammary Carcinoma Cell Spreading Is Jak2 Dependent*. Endocrinology 2000;141:1571-84. [DOI: 10.1210/endo.141.4.7426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
545 Song HY, Jeon ES, Jung JS, Kim JH. Oncostatin M induces proliferation of human adipose tissue-derived mesenchymal stem cells. Int J Biochem Cell Biol 2005;37:2357-65. [PMID: 15979922 DOI: 10.1016/j.biocel.2005.05.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
546 Sarkar S, Pollack BP, Lin K, Kotenko SV, Cook JR, Lewis A, Pestka S. hTid-1, a Human DnaJ Protein, Modulates the Interferon Signaling Pathway. Journal of Biological Chemistry 2001;276:49034-42. [DOI: 10.1074/jbc.m103683200] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
547 Duhé RJ, Clark EA, Farrar WL. Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein. Mol Cell Biochem 2002;236:23-35. [PMID: 12190118 DOI: 10.1023/a:1016186907376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
548 Abe M, Funakoshi-Tago M, Tago K, Kamishimoto J, Aizu-Yokota E, Sonoda Y, Kasahara T. The polycythemia vera-associated Jak2 V617F mutant induces tumorigenesis in nude mice. Int Immunopharmacol 2009;9:870-7. [PMID: 19327411 DOI: 10.1016/j.intimp.2009.03.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
549 Tsai Y, Chen Y, Chang D, Chen P, Lai J. Janus kinase/signal transducer and activator of transcription 3 signaling pathway is crucial in chemokine production from hepatocytes infected by dengue virus. Exp Biol Med (Maywood) 2011;236:1156-65. [DOI: 10.1258/ebm.2011.011060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
550 Now H, Yoo JY. AG490 and PF431396 Sensitive Tyrosine Kinase Control the Population Heterogeneity of Basal STAT1 Activity in Ube1l Deficient Cells. PLoS One 2016;11:e0159453. [PMID: 27427993 DOI: 10.1371/journal.pone.0159453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
551 Kim YH, Lee SH, Lee JY, Choi SW, Park JW, Kwon TK. Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase. Eur J Pharmacol 2004;494:1-9. [PMID: 15194445 DOI: 10.1016/j.ejphar.2004.04.040] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 4.7] [Reference Citation Analysis]
552 Ahmed-Choudhury J, Williams KT, Young LS, Adams DH, Afford SC. CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2. Cell Signal 2006;18:456-68. [PMID: 15970430 DOI: 10.1016/j.cellsig.2005.05.015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
553 Hurtado-Nedelec M, Csillag-Grange MJ, Boussetta T, Belambri SA, Fay M, Cassinat B, Gougerot-Pocidalo MA, Dang PM, El-Benna J. Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation. Haematologica 2013;98:1517-24. [PMID: 23975181 DOI: 10.3324/haematol.2012.082560] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
554 Suginaka R, Izui R, Inoue J, Muraoka Y, Yamaguchi K, Otsuka M, Umezawa K. Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand. Jpn J Cancer Res 1998;89:947-53. [PMID: 9818031 DOI: 10.1111/j.1349-7006.1998.tb00653.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
555 Ward AC, Hermans MH, Smith L, van Aesch YM, Schelen AM, Antonissen C, Touw IP. Tyrosine-Dependent and -Independent Mechanisms of STAT3 Activation by the Human Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Are Differentially Utilized Depending on G-CSF Concentration. Blood 1999;93:113-24. [DOI: 10.1182/blood.v93.1.113.401k33_113_124] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
556 Ellis A, Nice E, Weinstock J, Levitzki A, Burgess A, Webster L. High-performance liquid chromatographic analysis of the tyrphostin AG1478, a specific inhibitor of the epidermal growth factor receptor tyrosine kinase, in mouse plasma. Journal of Chromatography B: Biomedical Sciences and Applications 2001;754:193-9. [DOI: 10.1016/s0378-4347(00)00606-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
557 Fantini MC, Becker C, Kiesslich R, Neurath MF. Drug insight: novel small molecules and drugs for immunosuppression. Nat Clin Pract Gastroenterol Hepatol 2006;3:633-44. [PMID: 17068501 DOI: 10.1038/ncpgasthep0611] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
558 Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate. 2004;60:303-309. [PMID: 15264241 DOI: 10.1002/pros.20072] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 3.6] [Reference Citation Analysis]
559 Yamauchi K, Osuka K, Takayasu M, Usuda N, Nakazawa A, Nakahara N, Yoshida M, Aoshima C, Hara M, Yoshida J. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J Neurochem 2006;96:1060-70. [DOI: 10.1111/j.1471-4159.2005.03559.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 4.3] [Reference Citation Analysis]
560 Gouilleux-Gruart V, Debierre-Grockiego F, Gouilleux F, Capiod JC, Claisse JF, Delobel J, Prin L. Activated Stat related transcription factors in acute leukemia. Leuk Lymphoma 1997;28:83-8. [PMID: 9498707 DOI: 10.3109/10428199709058334] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 1.8] [Reference Citation Analysis]
561 Sansone P, Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol. 2012;30:1005-1014. [PMID: 22355058 DOI: 10.1200/jco.2010.31.8907] [Cited by in Crossref: 341] [Cited by in F6Publishing: 199] [Article Influence: 34.1] [Reference Citation Analysis]
562 Ritchie A, Braun SE, He J, Broxmeyer HE. Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e. Oncogene 1999;18:1465-77. [DOI: 10.1038/sj.onc.1202439] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
563 Gross ER, Hsu AK, Gross GJ. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3β. American Journal of Physiology-Heart and Circulatory Physiology 2006;291:H827-34. [DOI: 10.1152/ajpheart.00003.2006] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 7.8] [Reference Citation Analysis]
564 Davoodi-Semiromi A, Hassanzadeh A, Wasserfall CH, Droney A, Atkinson M. Tyrphostin AG490 agent modestly but significantly prevents onset of type 1 in NOD mouse; implication of immunologic and metabolic effects of a Jak-Stat pathway inhibitor. J Clin Immunol 2012;32:1038-47. [PMID: 22661285 DOI: 10.1007/s10875-012-9707-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
565 Shouda T, Hiraoka K, Komiya S, Hamada T, Zenmyo M, Iwasaki H, Isayama T, Fukushima N, Nagata K, Yoshimura A. Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. Cancer Letters 2006;231:176-84. [DOI: 10.1016/j.canlet.2005.01.042] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
566 Levy O, Granot Y. Arginine-Vasopressin Activates the JAK-STAT Pathway in Vascular Smooth Muscle Cells. Journal of Biological Chemistry 2006;281:15597-604. [DOI: 10.1074/jbc.m502750200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
567 Ozawa Y, Williams AH, Estes ML, Matsushita N, Boschelli F, Jove R, List AF. Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leukemia Research 2008;32:893-903. [DOI: 10.1016/j.leukres.2007.11.032] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
568 Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A 2001;98:9050-5. [PMID: 11481471 DOI: 10.1073/pnas.161283798] [Cited by in Crossref: 198] [Cited by in F6Publishing: 195] [Article Influence: 9.4] [Reference Citation Analysis]
569 Ward AC, van Aesch YM, Schelen AM, Touw IP. Defective Internalization and Sustained Activation of Truncated Granulocyte Colony-Stimulating Factor Receptor Found in Severe Congenital Neutropenia/Acute Myeloid Leukemia. Blood 1999;93:447-58. [DOI: 10.1182/blood.v93.2.447.402k37_447_458] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
570 Relloso M, Puig-kröger A, Pello OM, Rodríguez-fernández JL, de la Rosa G, Longo N, Navarro J, Muñoz-fernández MA, Sánchez-mateos P, Corbí AL. DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents. J Immunol 2002;168:2634-43. [DOI: 10.4049/jimmunol.168.6.2634] [Cited by in Crossref: 223] [Cited by in F6Publishing: 218] [Article Influence: 11.2] [Reference Citation Analysis]
571 van Garderen E, Swennenhuis J, Hellmén E, Schalken J. Growth hormone induces tyrosyl phosphorylation of the transcription factors Stat5a and Stat5b in CMT-U335 canine mammary tumor cells. Domestic Animal Endocrinology 2001;20:123-35. [DOI: 10.1016/s0739-7240(01)00088-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
572 Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng L, Huang X, Wang X, Sun B. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology. 2013;57:678-688. [PMID: 22821478 DOI: 10.1002/hep.25980] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
573 Watanabe S, Arai K. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Current Opinion in Genetics & Development 1996;6:587-96. [DOI: 10.1016/s0959-437x(96)80088-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
574 Hammarén HM, Virtanen AT, Raivola J, Silvennoinen O. The regulation of JAKs in cytokine signaling and its breakdown in disease. Cytokine 2019;118:48-63. [DOI: 10.1016/j.cyto.2018.03.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 21.3] [Reference Citation Analysis]
575 Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 1999;18:1309-20. [PMID: 10064597 DOI: 10.1093/emboj/18.5.1309] [Cited by in Crossref: 525] [Cited by in F6Publishing: 512] [Article Influence: 22.8] [Reference Citation Analysis]
576 Mulloy JC, Migone TS, Ross TM, Ton N, Green PL, Leonard WJ, Franchini G. Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV-2(pan-p)) transform T cells independently of Jak/STAT activation. J Virol 1998;72:4408-12. [PMID: 9557732 DOI: 10.1128/JVI.72.5.4408-4412.1998] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
577 Walker F, Kato A, Gonez LJ, Hibbs ML, Pouliot N, Levitzki A, Burgess AW. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Mol Cell Biol 1998;18:7192-204. [PMID: 9819406 DOI: 10.1128/MCB.18.12.7192] [Cited by in Crossref: 79] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
578 Haznedaroğlu IC, Arici M, Büyükaşik Y. A unifying hypothesis for the renin-angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway. Med Hypotheses 2000;54:80-3. [PMID: 10790731 DOI: 10.1054/mehy.1998.0830] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
579 Saxena NK, Vertino PM, Anania FA, Sharma D. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem 2007;282:13316-25. [PMID: 17344214 DOI: 10.1074/jbc.M609798200] [Cited by in Crossref: 127] [Cited by in F6Publishing: 85] [Article Influence: 8.5] [Reference Citation Analysis]
580 Wong CK, Lam CW. Clinical applications of cytokine assays. Adv Clin Chem 2003;37:1-46. [PMID: 12619704 DOI: 10.1016/s0065-2423(03)37005-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
581 Laurence A, Pesu M, Silvennoinen O, O'Shea J. JAK Kinases in Health and Disease: An Update. Open Rheumatol J 2012;6:232-44. [PMID: 23028408 DOI: 10.2174/1874312901206010232] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]
582 Bauvois B, Pramil E, Jondreville L, Chapiro E, Quiney C, Maloum K, Susin SA, Nguyen-Khac F. Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia. Cancers (Basel) 2020;12:E2124. [PMID: 32751884 DOI: 10.3390/cancers12082124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
583 Du Q, Wang L, Zhu H, Zhang S, Xu L, Zheng W, Liu X. The role of heterogeneous nuclear ribonucleoprotein K in the progression of chronic myeloid leukemia. Med Oncol 2010;27:673-9. [PMID: 19653139 DOI: 10.1007/s12032-009-9267-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
584 Takahara M, Kis LL, Nagy N, Liu A, Harabuchi Y, Klein G, Klein E. Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3. Int J Cancer 2006;119:2775-83. [PMID: 17013900 DOI: 10.1002/ijc.22139] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
585 Simon HU, Yousefi S, Dibbert B, Levi-Schaffer F, Blaser K. Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils. Eur J Immunol 1997;27:3536-9. [PMID: 9464845 DOI: 10.1002/eji.1830271256] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 3.4] [Reference Citation Analysis]
586 Levitzki A. Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacol Ther. 1999;82:231-239. [PMID: 10454200 DOI: 10.1016/s0163-7258(98)00066-7] [Cited by in Crossref: 143] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
587 Purwanti N, Karabasil MR, Matsuo S, Chen G, Javkhlan P, Azlina A, Hasegawa T, Yao C, Akamatsu T, Hosoi K. Induction of Sca-1 via activation of STAT3 system in the duct cells of the mouse submandibular gland by ligation of the main excretory duct. Am J Physiol Gastrointest Liver Physiol 2011;301:G814-24. [PMID: 21868636 DOI: 10.1152/ajpgi.00408.2010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
588 Koganti S, de la Paz A, Freeman AF, Bhaduri-McIntosh S. B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation. J Virol 2014;88:516-24. [PMID: 24173212 DOI: 10.1128/JVI.02601-13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
589 O'Brien KB, O'Shea JJ, Carter-Su C. SH2-B family members differentially regulate JAK family tyrosine kinases. J Biol Chem 2002;277:8673-81. [PMID: 11751854 DOI: 10.1074/jbc.M109165200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
590 Alim K, Bruyère A, Lescoat A, Jouan E, Lecureur V, Le Vée M, Fardel O. Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity. Expert Opin Drug Metab Toxicol 2021;17:259-71. [PMID: 33292029 DOI: 10.1080/17425255.2021.1862084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
591 Kok S, Hong C, Kuo MY, Wang C, Hou K, Lin Y, Galson DL, Lin S. Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: An implication for the pathogenesis of arthritis. Arthritis Rheum 2009;60:1451-62. [DOI: 10.1002/art.24452] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
592 Liu L, Paul A, MacKenzie CJ, Bryant C, Graham A, Plevin R. Nuclear factor kappa B is involved in lipopolysaccharide-stimulated induction of interferon regulatory factor-1 and GAS/GAF DNA-binding in human umbilical vein endothelial cells. Br J Pharmacol 2001;134:1629-38. [PMID: 11739238 DOI: 10.1038/sj.bjp.0704404] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
593 Beckles DL, Mascareno E, Siddiqui M. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy. Vascular Pharmacology 2006;45:350-7. [DOI: 10.1016/j.vph.2006.05.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
594 Liu T, Fei Z, Gangavarapu KJ, Agbenowu S, Bhushan A, Lai JC, Daniels CK, Cao S. Interleukin-6 and JAK2/STAT3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7TD1 multiple myeloma cells. Leuk Res 2013;37:1322-8. [PMID: 23871159 DOI: 10.1016/j.leukres.2013.06.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
595 Kalvakolanu DV. Alternate interferon signaling pathways. Pharmacol Ther 2003;100:1-29. [PMID: 14550502 DOI: 10.1016/s0163-7258(03)00070-6] [Cited by in Crossref: 68] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
596 Qian Y, Zhang HJ, Zhang H, Xu C, Zhao J, Zhu HL. Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents. Bioorg Med Chem 2010;18:4991-6. [PMID: 20594859 DOI: 10.1016/j.bmc.2010.06.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
597 Chen M, Cheng A, Candotti F, Zhou YJ, Hymel A, Fasth A, Notarangelo LD, O'Shea JJ. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol Cell Biol 2000;20:947-56. [PMID: 10629052 DOI: 10.1128/MCB.20.3.947-956.2000] [Cited by in Crossref: 96] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
598 Caldera V, Mellai M, Annovazzi L, Valente G, Tessitore L, Schiffer D. Stat3 expression and its correlation with proliferation and apoptosis/autophagy in gliomas. J Oncol 2008;2008:219241. [PMID: 19421400 DOI: 10.1155/2008/219241] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
599 Lai K, Chen Y, Po H, Lok K, Gong K, Ip NY. Identification of the Jak/Stat Proteins as Novel Downstream Targets of EphA4 Signaling in Muscle. Journal of Biological Chemistry 2004;279:13383-92. [DOI: 10.1074/jbc.m313356200] [Cited by in Crossref: 60] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
600 Kagami S, Nakajima H, Kumano K, Suzuki K, Suto A, Imada K, Davey HW, Saito Y, Takatsu K, Leonard WJ, Iwamoto I. Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 2000;95:1370-7. [DOI: 10.1182/blood.v95.4.1370.004k29_1370_1377] [Cited by in Crossref: 65] [Article Influence: 3.0] [Reference Citation Analysis]
601 Zhong Y, Wu J, Ma R, Cao H, Wang Z, Ding J, Cheng L, Feng J, Chen B. Association of Janus kinase 2 (JAK2) polymorphisms with acute leukemia susceptibility. Int J Lab Hematol 2012;34:248-53. [PMID: 22168550 DOI: 10.1111/j.1751-553X.2011.01386.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
602 Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, Kondo S, Priebe W, Kondo Y. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 2007;26:2435-44. [DOI: 10.1038/sj.onc.1210031] [Cited by in Crossref: 249] [Cited by in F6Publishing: 242] [Article Influence: 15.6] [Reference Citation Analysis]
603 Stein JV, Soriano SF, M'rini C, Nombela-Arrieta C, de Buitrago GG, Rodríguez-Frade JM, Mellado M, Girard JP, Martínez-A C. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood. 2003;101:38-44. [PMID: 12393730 DOI: 10.1182/blood-2002-03-0841] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 3.4] [Reference Citation Analysis]
604 Lolli G, Cozza G, Mazzorana M, Tibaldi E, Cesaro L, Donella-Deana A, Meggio F, Venerando A, Franchin C, Sarno S, Battistutta R, Pinna LA. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight. Biochemistry 2012;51:6097-107. [PMID: 22794353 DOI: 10.1021/bi300531c] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 9.2] [Reference Citation Analysis]
605 Ignarro RS, Vieira AS, Sartori CR, Langone F, Rogério F, Parada CA. JAK2 inhibition is neuroprotective and reduces astrogliosis after quinolinic acid striatal lesion in adult mice. J Chem Neuroanat 2013;48-49:14-22. [PMID: 23403094 DOI: 10.1016/j.jchemneu.2013.02.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
606 Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL. Functional Uncoupling of the Janus Kinase 3-Stat5 Pathway in Malignant Growth of Human T Cell Leukemia Virus Type 1-Transformed Human T Cells. J Immunol 2000;165:5097-104. [DOI: 10.4049/jimmunol.165.9.5097] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
607 VonDerLinden D, Ma X, Sandberg EM, Gernert K, Bernstein KE, Sayeski PP. Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity. Mol Cell Biochem 2002;241:87-94. [PMID: 12482029 DOI: 10.1023/a:1020829617779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
608 Menet CJ, Rompaey LV, Geney R. Advances in the discovery of selective JAK inhibitors. Prog Med Chem 2013;52:153-223. [PMID: 23384668 DOI: 10.1016/B978-0-444-62652-3.00004-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
609 Soldevila G, García-zepeda EA. The role of the Jak-Stat pathway in chemokine-mediated signaling in T lymphocytes. Signal Transduction 2007;7:427-38. [DOI: 10.1002/sita.200700144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
610 Zaleskas VM, Krause DS, Lazarides K, Patel N, Hu Y, Li S, Van Etten RA. Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F. PLoS One 2006;1:e18. [PMID: 17183644 DOI: 10.1371/journal.pone.0000018] [Cited by in Crossref: 180] [Cited by in F6Publishing: 167] [Article Influence: 11.3] [Reference Citation Analysis]
611 Liu Y, He X, Sui Y, Yu R, Xu G. Transcription factor IKZF1 is degraded during the apoptosis of multiple myeloma cells induced by kinase inhibition. FEBS Lett 2015;589:2233-40. [PMID: 26183205 DOI: 10.1016/j.febslet.2015.06.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
612 Yuan K, Ye J, Liu Z, Ren Y, He W, Xu J, He Y, Yuan Y. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. J Exp Clin Cancer Res 2020;39:9. [PMID: 31928530 DOI: 10.1186/s13046-019-1514-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
613 Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol 2014;15:717-26. [PMID: 24952503 DOI: 10.1038/ni.2915] [Cited by in Crossref: 236] [Cited by in F6Publishing: 233] [Article Influence: 29.5] [Reference Citation Analysis]
614 Militi S, Chiapparino C, Testa U, Carminati P, De Santis R, Serlupi-crescenzi O. Role of IL-6 and CD23 in the resistance to growth arrest and apoptosis in LCL41 B lymphoma cells. Cytokine 2005;31:314-23. [DOI: 10.1016/j.cyto.2005.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
615 Umezawa K, Nakazawa K, Uchihata Y, Otsuka M. Screening for inducers of apoptosis in apoptosis-resistant human carcinoma cells. Advances in Enzyme Regulation 1999;39:145-56. [DOI: 10.1016/s0065-2571(98)00022-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
616 Rider L, Shatrova A, Feener EP, Webb L, Diakonova M. JAK2 Tyrosine Kinase Phosphorylates PAK1 and Regulates PAK1 Activity and Functions. Journal of Biological Chemistry 2007;282:30985-96. [DOI: 10.1074/jbc.m701794200] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
617 Ducret T, Vacher A, Vacher P. Effects of Prolactin on Ionic Membrane Conductances in the Human Malignant Astrocytoma Cell Line U87-MG. Journal of Neurophysiology 2004;91:1203-16. [DOI: 10.1152/jn.00710.2003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
618 Chang K, Tsai C, Chiou Y, Chiu C, Jeng K, Huang CF. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2005;289:L446-53. [DOI: 10.1152/ajplung.00089.2005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
619 Luo H, Rose P, Barber D, Hanratty WP, Lee S, Roberts TM, D'Andrea AD, Dearolf CR. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol 1997;17:1562-71. [PMID: 9032284 DOI: 10.1128/MCB.17.3.1562] [Cited by in Crossref: 183] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
620 Meyer L, Deau B, Forejtníková H, Duménil D, Margottin-Goguet F, Lacombe C, Mayeux P, Verdier F. beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 2007;109:5215-22. [PMID: 17327410 DOI: 10.1182/blood-2006-10-055350] [Cited by in F6Publishing: 53] [Reference Citation Analysis]
621 Deng J, Hua K, Lesser SS, Greiner AH, Walter AW, Marrero MB, Harp JB. Interleukin-4 mediates STAT6 activation in 3T3-L1 preadipocytes but not adipocytes. Biochem Biophys Res Commun 2000;267:516-20. [PMID: 10631093 DOI: 10.1006/bbrc.1999.1993] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
622 Lee SO, Lou W, Hou M, Onate SA, Gao AC. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway. Oncogene 2003;22:7981-8. [DOI: 10.1038/sj.onc.1206735] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
623 Lee-Sherick AB, Linger RM, Gore L, Keating AK, Graham DK. Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development. Br J Haematol 2010;151:295-311. [PMID: 20813012 DOI: 10.1111/j.1365-2141.2010.08282.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
624 Van Vlierberghe P, Pieters R, Beverloo HB, Meijerink JP. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol 2008;143:153-68. [PMID: 18691165 DOI: 10.1111/j.1365-2141.2008.07314.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 7.7] [Reference Citation Analysis]
625 Liu R, Arai K, Watanabe S. Analysis of antiapoptosis activity of human GM-CSF receptor. J Allergy Clin Immunol 2000;106:S10-8. [PMID: 10887329 DOI: 10.1067/mai.2000.106772] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
626 Levitzki A. Protein Tyrosine Kinase Inhibitors as Therapeutic Agents. In: Waldmann H, editor. Bioorganic Chemistry of Biological Signal Transduction. Berlin: Springer Berlin Heidelberg; 2001. pp. 1-15. [DOI: 10.1007/3-540-45035-1_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
627 Tøndel K, Anderssen E, Drabløs F. Protein Alpha Shape Similarity Analysis (PASSA): a new method for mapping protein binding sites. Application in the design of a selective inhibitor of tyrosine kinase 2. J Comput Aided Mol Des 2002;16:831-40. [PMID: 12825796 DOI: 10.1023/a:1023840914434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
628 Liu P, Zhao L, Xu X, Liu F, Zhang W, Zhou C, Chen J, Pan Y, Du Y, Yang J, Wang Q. N6-Substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells. Cancer Letters 2014;354:43-57. [DOI: 10.1016/j.canlet.2014.07.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
629 Zhu T, Lobie PE. Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone. Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis. J Biol Chem 2000;275:2103-14. [PMID: 10636915 DOI: 10.1074/jbc.275.3.2103] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 2.8] [Reference Citation Analysis]
630 Yun HJ, Yoon JH, Lee JK, Noh KT, Yoon KW, Oh SP, Oh HJ, Chae JS, Hwang SG, Kim EH, Maul GG, Lim DS, Choi EJ. Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. EMBO J 2011;30:2465-76. [PMID: 21572393 DOI: 10.1038/emboj.2011.152] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
631 Bareng J, Jilani I, Gorre M, Kantarjian H, Giles F, Hannah A, Albitar M. A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry. Leuk Lymphoma 2007;48:2189-95. [PMID: 17926180 DOI: 10.1080/10428190701607576] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
632 Mascareno E, El-shafei M, Maulik N, Sato M, Guo Y, Das DK, Siddiqui M. JAK/STAT Signaling Is Associated With Cardiac Dysfunction During Ischemia and Reperfusion. Circulation 2001;104:325-9. [DOI: 10.1161/01.cir.104.3.325] [Cited by in Crossref: 117] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
633 Li XJ, Ma QY, Jiang YM, Bai XH, Yan ZY, Liu Q, Pan QX, Liu YY, Chen JX. Xiaoyaosan exerts anxiolytic-like effects by down-regulating the TNF-α/JAK2-STAT3 pathway in the rat hippocampus. Sci Rep 2017;7:353. [PMID: 28336920 DOI: 10.1038/s41598-017-00496-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
634 Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, Nagata K, Yoshimura A. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001;108:1781-8. [PMID: 11748261 DOI: 10.1172/JCI13568] [Cited by in Crossref: 243] [Cited by in F6Publishing: 105] [Article Influence: 12.2] [Reference Citation Analysis]
635 Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L, Pinna LA, Zambello R, Semenzato G, Donella-deana A. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 2005;115:369-78. [DOI: 10.1172/jci200522094] [Cited by in Crossref: 181] [Article Influence: 10.6] [Reference Citation Analysis]
636 Chakravarti N, Myers JN, Aggarwal BB. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 2006;119:1268-75. [PMID: 16642480 DOI: 10.1002/ijc.21967] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
637 Andl CD, Mizushima T, Oyama K, Bowser M, Nakagawa H, Rustgi AK. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am J Physiol Gastrointest Liver Physiol 2004;287:G1227-37. [PMID: 15284024 DOI: 10.1152/ajpgi.00253.2004] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
638 Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001;412:641-7. [PMID: 11493922 DOI: 10.1038/35088074] [Cited by in Crossref: 700] [Cited by in F6Publishing: 650] [Article Influence: 33.3] [Reference Citation Analysis]
639 Takahashi T, Abe H, Arai H, Matsubara T, Nagai K, Matsuura M, Iehara N, Yokode M, Nishikawa S, Kita T, Doi T. Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis. J Biol Chem 2005;280:7100-6. [PMID: 15591053 DOI: 10.1074/jbc.M411064200] [Cited by in Crossref: 45] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
640 Duhé RJ, Farrar WL. Structural and mechanistic aspects of Janus kinases: how the two-faced god wields a double-edged sword. J Interferon Cytokine Res 1998;18:1-15. [PMID: 9475661 DOI: 10.1089/jir.1998.18.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
641 Deininger MW, Goldman JM, Lydon N, Melo JV. The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells. Blood 1997;90:3691-8. [DOI: 10.1182/blood.v90.9.3691] [Cited by in Crossref: 433] [Article Influence: 17.3] [Reference Citation Analysis]
642 Kudoh S, Komuro I, Hiroi Y, Zou Y, Harada K, Sugaya T, Takekoshi N, Murakami K, Kadowaki T, Yazaki Y. Mechanical Stretch Induces Hypertrophic Responses in Cardiac Myocytes of Angiotensin II Type 1a Receptor Knockout Mice. Journal of Biological Chemistry 1998;273:24037-43. [DOI: 10.1074/jbc.273.37.24037] [Cited by in Crossref: 104] [Cited by in F6Publishing: 83] [Article Influence: 4.3] [Reference Citation Analysis]
643 Hibbert L, Johnston JA. Cytokine signalling and disease. Expert Opin Ther Targets 2001;5:641-53. [PMID: 12540275 DOI: 10.1517/14728222.5.6.641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
644 Samardzija M, Wenzel A, Aufenberg S, Thiersch M, Remé C, Grimm C. Differential role of Jak-STAT signaling in retinal degenerations. FASEB J 2006;20:2411-3. [PMID: 16966486 DOI: 10.1096/fj.06-5895fje] [Cited by in Crossref: 74] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
645 Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997;272:24684-90. [PMID: 9305939 DOI: 10.1074/jbc.272.39.24684] [Cited by in Crossref: 179] [Cited by in F6Publishing: 167] [Article Influence: 7.2] [Reference Citation Analysis]
646 Marschall M, Stein-Gerlach M, Freitag M, Kupfer R, van den Bogaard M, Stamminger T. Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97. J Gen Virol 2001;82:1439-50. [PMID: 11369889 DOI: 10.1099/0022-1317-82-6-1439] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 3.0] [Reference Citation Analysis]
647 Ward AC, van Aesch YM, Schelen AM, Touw IP. Defective Internalization and Sustained Activation of Truncated Granulocyte Colony-Stimulating Factor Receptor Found in Severe Congenital Neutropenia/Acute Myeloid Leukemia. Blood 1999;93:447-58. [DOI: 10.1182/blood.v93.2.447] [Cited by in Crossref: 94] [Article Influence: 4.1] [Reference Citation Analysis]
648 Hwang MS, Yu N, Stinson SY, Yue P, Newman RJ, Allan BB, Dornan D. miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer. PLoS One 2013;8:e66502. [PMID: 23776679 DOI: 10.1371/journal.pone.0066502] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 9.6] [Reference Citation Analysis]
649 Silvennoinen O. Immunodeficiencies and haematological disorders--direct connections to cellular signalling pathways. Ann Med 1997;29:519-29. [PMID: 9562518 DOI: 10.3109/07853899709007476] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
650 Ohm JE, Baylin SB. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 2007;6:1040-3. [PMID: 17457052 DOI: 10.4161/cc.6.9.4210] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 4.7] [Reference Citation Analysis]
651 Baus D, Pfitzner E. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells. Int J Cancer 2006;118:1404-13. [PMID: 16206268 DOI: 10.1002/ijc.21539] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
652 Kang MK, Kang SK. Interleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/STAT3 pathway with EGF-induced MAPK phosphorylation. Cell Prolif 2008;41:377-92. [PMID: 18485152 DOI: 10.1111/j.1365-2184.2008.00537.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
653 Yamamoto N, Tanida M, Kasahara R, Sobue K, Suzuki K. Leptin inhibits amyloid β-protein fibrillogenesis by decreasing GM1 gangliosides on the neuronal cell surface through PI3K/Akt/mTOR pathway. J Neurochem 2014;131:323-32. [PMID: 25039425 DOI: 10.1111/jnc.12828] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
654 Traxler P. Tyrosine kinase inhibitors in cancer treatment (Part II). Expert Opinion on Therapeutic Patents 2005;8:1599-625. [DOI: 10.1517/13543776.8.12.1599] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
655 Eufemi M, Cocchiola R, Romaniello D, Correani V, Di Francesco L, Fabrizi C, Maras B, Schininà ME. Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid. Neurochem Int 2015;81:48-56. [PMID: 25633229 DOI: 10.1016/j.neuint.2015.01.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
656 Ni J, Shen Y, Wang Z, Shao DC, Liu J, Kong YL, Fu LJ, Zhou L, Xue H, Huang Y, Zhang W, Yu C, Lu LM. P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells. Acta Pharmacol Sin 2014;35:1157-66. [PMID: 25088002 DOI: 10.1038/aps.2014.54] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
657 Cruz MT, Duarte CB, Gonçalo M, Carvalho AP, Lopes MC. Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells. Am J Physiol 1999;277:C1050-7. [PMID: 10600756 DOI: 10.1152/ajpcell.1999.277.6.C1050] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
658 Fernandes SE, Saini DK. The ERK-p38MAPK-STAT3 Signalling Axis Regulates iNOS Expression and Salmonella Infection in Senescent Cells. Front Cell Infect Microbiol 2021;11:744013. [PMID: 34746026 DOI: 10.3389/fcimb.2021.744013] [Reference Citation Analysis]
659 Yagisawa M, Saeki K, Okuma E, Kitamura T, Kitagawa S, Hirai H, Yazaki Y, Takaku F, Yuo A. Signal transduction pathways in normal human monocytes stimulated by cytokines and mediators. Experimental Hematology 1999;27:1063-76. [DOI: 10.1016/s0301-472x(99)00040-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
660 Kim DW, Cochran BH. JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase. Mol Cell Biol 2001;21:3387-97. [PMID: 11313464 DOI: 10.1128/MCB.21.10.3387-3397.2000] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
661 Mankan AK, Greten FR. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors. Expert Opin Investig Drugs 2011;20:1263-75. [PMID: 21751940 DOI: 10.1517/13543784.2011.601739] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
662 He G, Karin M. NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res 2011;21:159-68. [PMID: 21187858 DOI: 10.1038/cr.2010.183] [Cited by in Crossref: 648] [Cited by in F6Publishing: 642] [Article Influence: 54.0] [Reference Citation Analysis]
663 Lamb P, Seidel HM, Stein RB, Rosen J. Chapter 27. The Role of JAKs and STATs in Transcriptional Regulation by Cytokines. Elsevier; 1996. pp. 269-78. [DOI: 10.1016/s0065-7743(08)60466-2] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
664 Luo C, Laaja P. Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs. Drug Discovery Today 2004;9:268-75. [DOI: 10.1016/s1359-6446(03)03014-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
665 Li WQ, Dehnade F, Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol. 2001;166:3491-3498. [PMID: 11207308 DOI: 10.4049/jimmunol.166.5.3491] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 5.5] [Reference Citation Analysis]
666 Ma AC, Ward AC, Liang R, Leung AY. The role of jak2a in zebrafish hematopoiesis. Blood 2007;110:1824-30. [PMID: 17545503 DOI: 10.1182/blood-2007-03-078287] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]